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CHAPTER 1:  THE STRUCTURE, FUNCTION AND REGENERATION OF BONE 
Background 
 Orthopaedic surgery is a field of healthcare concerned with the diagnosis and treatment 
of disorders of the musculoskeletal system resulting from trauma, congenital abnormalities, 
tissue degeneration, or other pathology.  These disorders may effect any structural component of 
the musculoskeletal system, including cartilage, tendon, ligaments, muscle and bone.  
Frequently, injury or pathology affecting these structural components result in extreme 
dysfunction, pain and an overall reduction in the patient’s quality of life.  The societal impact of 
musculoskeletal disorders is significant both from a financial and social perspective.  It is 
estimated that more than one in four Americans have musculoskeletal pathology or injury 
requiring direct medical attention, which is associated with the expenditure of $849 Billion in 
indirect costs annually (www.boneandjointburden.org).  Musculoskeletal injuries and disorders 
account for nearly one third of work days missed by employees.   
 Owing to the significant impact of musculoskeletal disorders, continuous research and 
development work is being performed by scientists and physicians to enhance patient outcomes 
associated with orthopaedic surgical procedures.  One of the main methods of improving patient 
outcomes of surgical procedures is to enhance the rate of healing of the tissue being repaired.  As 
the primary structural support of the body, bone has received a significant amount of attention in 
terms of research aimed at improving healing and regeneration of this important tissue.  Most 
modern research in the area of bone healing centers on the use of tissue engineering techniques, 
including the use of growth factors, multi-potent cells and scaffolds.  Research into novel 
scaffold constructs for structural bone tissue engineering has lagged behind the considerable 
advancements made in growth factor and stem cells research.   
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While numerous materials have been developed to support new bone growth, the vast 
majority of these constructs lack the static mechanical properties to support in vivo 
biomechanical loading.  Non-resorbable materials, such as porous metals, possess adequate 
compressive strength, but their permanence in vivo represents a challenge to surgeons 
performing revision surgeries.  Device permanence also increases the patients risk for late-onset 
infection.  Ceramic materials, such as sintered calcium phosphates, are attractive from the 
standpoint of biocompatibility, favorable surface chemistry and porosity.  The brittle behavior of 
these materials is concerning in the setting of structural bone grafting, especially if there is a 
bending or torsional component to biomechanical loading in the desired anatomic location.  
Resorbable polymers, especially those based on lactic and glycolic acid are attractive candidate 
materials.  The predictable and labile degradation profile and nearly four decades of in vivo use 
are desirable characteristics.  However, concerns persist regarding both the initial mechanical 
properties and loss of mechanical strength as a function of construct degradation.  This concern 
is especially warranted considering the relatively poor mechanical behavior of resorbable 
polymer constructs with a porous morphology.   
    A considerable amount of new research is now focused on reinforcing resorbable 
polymer matrices with nanostructured filler materials, such as hydroxyapatite, -tricalcium 
phosphate and phosphate glasses.  The addition of these filler materials has been associated with 
improvements in in vitro osteoblast response, due to their biologic activity.  However, only 
modest gains in mechanical strength have been reported with these filler particles in lactic and 
glycolic acid-based polymer matrices.  The lack of significant improvements in reinforcement 
have been attribute to the inability to adequately disperse the ceramic particulate in the polymer 
matrix.  Additionally, it is hypothesized that the poor interaction between polymer chains and the 
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ceramic materials does not allow for the effective restriction of polymer chain mobility, which is 
necessary for significant improvements in mechanical strength. 
A promising new method for synthesizing porous, resorbable polymer nanocomposite 
materials has been developed (Baker et al., 2008; Baker et al., 2011).  This method shows 
promise in terms of the rapid synthesis of nanocomposites suitable for in vivo load-bearing bone 
graft substitute applications.  The method consists of dispersing organically-modified 
Montmorillonite clays (nanoclay) in a matrix of poly(D-lactide) (PDLA) using supercritical 
carbon dioxide (scCO2) processing.  In addition to effectively dispersing the nanoclay throughout 
the PDLA matrix, scCO2 processing simultaneously imparts an interconnected porous 
morphology to the material.  The porous morphology is of the resulting nanocomposite construct 
is similar that of human cancellous bone.  Resulting compressive mechanical properties are 
similar to normal human cortico-cancellous bone.  In vitro and in vivo analyses illustrate the 
ability of the scCO2-processed resorbable polymer nanocomposites to support bone formation, 
thus making it an ideal candidate for bone graft substitute applications. 
Structure of Human Bone 
 In order to effectively develop a material to replace a tissue, a knowledge about the 
structure and biology of the tissue is required.  Bone is a true composite material comprised of a 
predominantly organic matrix, reinforced by inorganic consituents.  The organic matrix of bone 
consists primarily of Type I collagen (90%), with additional collagens, non-collagenous 
extracellular matrix proteins, lipids, growth factors and cytokines.  This organic matrix is 
reinforced by inorganic substances, principally hydroxyapatite.  Hydroxyapatite is a calcium 
phosphate-based mineral (Ca10(PO4)6(OH)2), which is present within the collagenous organic 
matrix as plate-like crystals approximately 20-80 nm in length and 2-5 nm in thickness.  
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Numerous elemental substitutions are possible within hydroxyapatite crystals, including Mg
2+
, 
Sr
2+
, Na
+
 and K
+
 substituting for calcium.  Phosphate groups can be replaced by carbonate 
groups, or hydrogenated phosphates, while the hydroxyl group can also become carbonated, or 
fluorinated.  These substitutions depend on age, anatomic location and the presence of disease 
states and tend to have a large effect on solubility, rather than structural properties (Bolstrom et 
al., 2000)   
   On a macroscopic scale, human long bones (i.e. femur, humerus, tibia, etc.) are 
comprised of a dense outer shell called cortical bone.  The dense cortical bone transitions 
abruptly to a porous morphology referred to as cancellous bone.  Cortical bone is comprised of 
individual functional units called osteons, which are oriented longitudinally in most long bones, 
as shown in Figure 1.  Osteons are composed of rings of cortical bone, referred to as lamellae, 
which surround the Haversian canal.  Bone’s neurovascular supply runs through these canals 
after being fed from the outer sheath of tissue known as the periosteum.  Osteons are bonded to 
one another at the periphery by the cement line, which is a region rich in glycosaminoglycans.  
Volkmann’s canals run in a pseudo-tangential path and act as the connection between individual 
osteons and also serve as connections between the osteon and periosteum.   
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Figure 1.  Illustration of the hierarchical structure of cortical and cancellous bone.  (Image 
taken from Haeys WC: Biomechanics of cortical and trabecular bone: Implications for 
assessment of fracture risk, in Basic Orthopaedic Biomechanics.  New York, NY, Raven Press, 
1991, pp 93-142.) 
 The porous core of the long bone is comprised of cancellous bone, which is extremely 
porous in morphology, but rigid enough to withstand biomechanical loading.  On an 
ultrastructural and compositional level, cancellous bone is identical to that of cortical bone.  The 
main difference is the density of the tissue.  As previously mentioned, cortical bone is comprised 
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of densely packed osteons running in a longitudinal direction, parallel to the primary direction of 
biomechanical loading.  Cancellous bone is comprised of a network of interconnected trabecular 
struts, as shown in Figure 2, and does not contain the same Haversian system that cortical bone 
does.  Depending on the anatomic location and even the location within the long bone, the 
morphology of the functional units (trabeculae) of cancellous bone vary from being rod-like to 
plate-like.  Similar to cortical bone, trabeculae are composed of lamellae, which are oriented in a 
longitudinal fashion, rather than concentrically.   
 
Figure 2.  Interconnected porous morphology of human cancellous bone.  Image taken from 
www.sciencephoto.com. 
Cell Biology of Bone 
 Functionally, bone hosts three distinct cell types, which include osteoblasts, osteocytes 
and osteoclasts.  Bone is the only tissue that contains two specific cell types that are responsible 
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for tissue formation and tissue destruction.  Tissue formation and destruction is a normal process 
within human bone and relies on the coupling between osteoblast and osteoclast function.  
Osteoclasts are the cell type responsible for resorption of bone and are descended from marrow-
derived hematopoietic progenitor cells that additionally give rise to a monocytic lineage.  Mature 
osteoclasts reside within the structure of bone in small cavities called Howships lacunae and 
express tartrate-resistant acid phosphatase (TRAP).  In order to resorb bone, osteoclasts attach to 
the proposed site of resorption through integrin binding.  Once attached, osteoclasts utilize a 
carbonic anhydrase system to produce pH-lowering hydrogen ions.  The significant reduction in 
local pH solubilizes the inorganic constituent of bone and hydrolytically digests the organic 
matrix.   
 The anabolic counterpart to an osteoclasts is the osteoblast.  Osteoblasts line surfaces of 
bone and express Type I collagen and other phenotypic markers, including osteocalcin, bone 
sialoprotein and several other extracellular matrix proteins.  The extracellular matrix produced 
by osteoblasts is referred to as osteoid and acts as an interface between the osteoblast and host 
bone.  Osteoblasts are responsible for regulating the process of mineralization, which occurs in 
two specific phases: nucleation and growth (Bolstrom et al., 2000).  The nucleation phase of 
mineralization consists of a local supersaturation of precipitating species, including Ca
2+
 which 
is accomplished by extracellular secretion by osteoblasts.  Following the build-up of 
precipitating species, nucleation sites are exposed on the osteoid extracellular matrix.  The 
nucleation of Ca
2+
 and PO4
-
 groups is followed by a rapid accumulation and growth phase.  The 
addition of more hydroxyapatite crystals during this phase improves the rigidity of the substrate 
and provides the structural basis of new bone formation. 
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 Osteocytes are another integral cell component of bone.  Osteocytes are actually 
osteoblasts that have been completely surrounded by mineralized osteoid and are considered to 
be the terminal phase of the osteoblastic lineage.  Within a section of cortical bone, osteocytes 
are distributed in concentric rings of the osteon.  The immobile osteocytes communicate with 
each other by extended cell processes that travel through the canaliculi of bone (Keaveny and 
Hall, 1993).  Osteocyte communication, which is both autocrine and paracrine (communicating 
directly with osteoblasts on the bone surface) in nature can help to regulate the homeostasis of 
bone and is implicated in one of the main driving forces of new bone remodeling (Bolstrom et 
al., 2000).    
Bone Remodeling 
 The function of osteoblasts and osteoclasts are coupled during the process of bone 
remodeling by a distinct set of pathways.  Bone remodeling is necessary for two distinct reasons: 
1. maintenance of systemic (circulating) calcium concentrations and 2. optimization of bone 
geometry and structure for adequate load bearing capacity.  For the purposes of this discussion, 
we will focus on the second reason.  It is known that new bone forms and existing bone remodels 
according to the mechanical loading that it experiences; a property known as Wolff’s Law.  This 
mechanism optimizes the geometric and material properties of bone based on predominant 
loading amplitudes, frequencies and directions.  Even in skeletally mature humans, bone 
continuously remodels as a function of body mass index, level of activity, diet and pathology. 
While the exact mechanisms of how mechanical forces are converted to cell-level 
communication are unknown, it is understood that the process is dependent on the coupling of 
anabolic and catabolic activity by osteoblasts and osteoclasts, respectively.  The functional 
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coupling of these cells is accomplished through a variety of physicochemical and biochemical 
signals.  In terms of physical signaling, osteoclast-mediated bone resorption can be mediated by 
osteoblast signaling.  Upon exposure to elevated levels of 1,25-dihydroxyvitamin D3, 
osteoblastic lining cells are stimulated to contract, which exposes mineralized osteoid.  
Activation of osteoclastic resorption requires exposure of mineralized matrix, as well as 
exposure to matrix-bound proteins.  Osteoblast surfaces express receptor activator for nuclear 
factor- ligand (RANKL) (Bolstrom et al., 2000).  RANKL is a cell surface protein that is 
necessary for receptor activator for nuclear factor-- (RANK) induced activation of nuclear 
factor- (NF-), as well as nuclear factor of activated T cells (NFATc1).  Activation of NF-
 and NFATc1 stimulates active resoprtion, as well as the recruitment and differentiation of 
osteoclast precursors.  To inhibit resorption, other local osteoblasts begin to express 
osteoprotegerin (OPG).  OPG binds to RANKL on osteoblast surfaces, which eliminates NF- 
and NFATc1 activation and brings the process of resorption to a halt.  Active degradation of the 
bone results in the release of growth factors with osteogenic activity, including bone 
morphogetic proteins (BMPs), which are members of the transforming growth factor-beta (TGF-
) superfamily of proteins.  Release of these growth factors from the matrix results in increased 
matrix production by osteoblasts.  As shown, the process of osteoclastic bone resorption and 
osteoblastic bone formation is a continuous feedback loop relying with each cell relying on the 
function of the other to maintain homeostasis.                  
Fracture Healing and Bone Regeneration 
 Despite the hierchical structure of human cortical and cancellous bone and the complex 
cellular basis for homeostatic balance between anabolism and catabolism, bone is still prone to 
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mechanical failure.  Fractures accounted for over 20% of all reported musculoskeletal injuries in 
2008 (www.boneandjointburden.org).  Long bones of the upper and lower extremities are the 
most common anatomic locations of these fractures, followed closely by fractures of the 
vertebral column.  Severe fractures are associated with significant physical limitations and the 
greatest number of missed days of work compared to any other type of musculoskeletal injury 
(www.aaos.org).   
 Bone is a tissue that does have a relatively potent intrinsic healing mechanism in the 
event of fracture (Day et al., 2000).  Depending on the magnitude, direction and mode of 
loading, immediately upon fracture, there is a disruption in the structural aspect of the tissue, its 
blood supply and surrounding soft tissues.  Attending physicians attempt to reduce the fracture, 
which involves the direct application of force to restore the normal anatomy of the fractured 
bone.  Depending on the type of injury, stability of the reduced fracture and anatomic location, 
the extremity affected by the fracture may be placed in a cast to reduce mobility.  In other 
situations, open reduction and internal fixation (ORIF) is necessary.  In the case of ORIF, 
metallic implants, such as intramedullary nails or screw and plate constructs will be used to 
create rigid fixation at the site of fracture.  Both the quality of the fracture reduction and the 
degree of fixation used dictate the healing response of the bone.  Primary cortical healing is one 
such healing response, which entails the attempt by the bone to re-establish osteon-osteon 
contact between the fracture fragments.  Gaps that persist between fracture fragments after 
reduction become vascularized and a callus forms.  The callus consists of a milieu of cytokines 
which direct neoangiogenesis, facilitate cellular infiltration to the fracture site and provide the 
biochemical impetus for healing.  MSCs differentiate towards an osteoblastic lineage and begin 
to express osteoid, which later becomes mineralized.  These initial phases of osteogenesis occur 
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in the absence of osteoclastic bone resorption, as the direct need is for tissue anabolism.  Days 
after this period of pure anabolic response at the fracture site, osteoclastogenesis occurs.  
Osteoclasts activate and begin to chemically debride any non-viable bone at the fracture site.  
The fracture callus is then resorbed and osteoblast-osteoclast coupling occurs to initiate the 
process of remodeling.  With an appropriately rigid reduction and fracture fixation, stresses and 
strains will still be effectively transmitted to the tissue, as the patient is encouraged to begin 
using the affected limb.  Osteoclasts form cutting cones to remodel the newly formed bone to be 
optimized for bearing of biomechanical loads (Bolstrom et al., 2000; Day et al., 2000). 
 Secondary healing is another mechanism by which fractures can heal.  Unlike primary 
healing, secondary healing does not involve the re-establishment of osteonal contact between the 
fracture fragments.  Instead, a potent reaction by the bone’s outer sheath-like covering 
(periosteum) immediate initiates the formation of a callus that covers the entire fracture site (Day 
et al., 2000).  The biochemical and biologic microenvironment of the callus contains a high 
concentration of endogenous promoters of neoangiogenesis and osteogenesis.  Host osteoblasts 
in each of the fracture fragments are encouraged to excrete a collagenous extracellular matrix.  
Secondary healing often involves bone formation by endochondral ossification.  This method of 
bone formation mimics embryonic bone formation and involves the formation of a collagenous 
template by MSCs.  The collagenous template is subsequently mineralized to form highly 
functional bone tissue in a relatively short period of time.  Similar to primary healing, osteoclasts 
begin to remodel the newly formed bone to ensure a return to normal weight bearing status with 
minimal dysfunction. 
The Need for Bone Grafting 
 12 
 
 
Despite the ability of bone to heal through a variety of intrinsic processes and pathways, 
several clinical situations arise where the patient’s healing and regeneration response is 
insufficient to provide a return of the bone to a normal structure.  Measures are taken by 
surgeons to restore the load bearing capacity of the bone by augmenting the site of bone injury or 
dysfunction with biologic, or synthetic constructs.  These constructs are meant to serve not only 
as load bearing structures, but also scaffolds onto which the patient’s new bone will form.  
Sometimes these constructs contain endogenous, or exogenous factors that promote the 
recruitment of stem cells to the site to speed the rate and amount of new bone formation.  
Regardless of the configuration, these constructs are referred to as bone grafts and are used quite 
frequently in orthopaedic surgery.  In 2003, over 1 million bone grafting procedures were 
performed in the United States alone (www.aaos.org).  While use of bone grafting in 
musculoskeletal trauma situations is obvious, there are two other scenarios that account for a 
significant portion of the number of bone grafting procedures performed each year.  As both of 
these scenarios have become increasingly more common, even over the last decade, it is 
pertinent to discuss the application of bone grafting in these situations.              
Bone Grafts for Osseous Neoplasms 
 The presence of malignant or benign neoplasms, or tumors, within osseous tissue is a 
relatively common occurrence (Clohisy 2000).  Several types of benign tumors exist, including 
aneurysmal bone cysts, osteoid osteomas and osteochondromas.  Aneurysmal bone cysts 
frequently occur as a result of a pre-existing bone tumor, which can lead to increases in local 
blood flow.  This increase in local blood flow, as well as local blood pressure cause the 
formation of a cyst in a location previously occupied by the bone tumor.  These types of tumors 
can arise on the surface of a bone, or remain confined within the marrow cavity.  Osteoid 
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osteomas are small focal lesions that tend to occur in the vertebrae and are characterized by a 
dense area of random oriented (woven) bone, fibrovascular tissue with a focal area of osteolysis 
(bone resorption) and a dense ring of sclerotic (non-viable) bone (Clohisy 2000).  
Osteochondromas are tumors that present as osseous outgrowths on a bone.  The outgrowth often 
has a cap of cartilage at the most distal end and tend to affect the long bones of the extremities.  
Malignant tumors of bone include osteosarcomas, Ewing’s sarcomas and secondary tumors 
arising from metastatic cancer.  Malignant tumors tend to be quite aggressive and destructive in 
nature.  Osteosarcoma is the most common primary osseous tumor and occurs frequently in the 
pediatric population.  Ewing’s sarcoma is another malignancy that tends to affect the adolescent 
population and is characterized by an expansile lesion, usually found in the femur, humerus or 
tibia. 
 Aside from presenting with constitutional symptoms (fever, chills, night sweats) and the 
insidious onset of pain, another common clinical presentation of a bone tumor is fracture of a 
bone from a seemingly low energy event.  Frequently, a patient will describe falling from a 
standing height and present with a fracture.  Upon analysis of X-rays, the presence of a lesion is 
in the region of the fracture is observed.  The so-called “pathologic fracture” is a function of the 
structural compromise of a bone affected by either a benign or malignant tumor (Day et al., 
2000).  All of the above-described benign and malignant tumors are associated with focal 
disruption of cortical bone in load bearing anatomic locations, including the vertebrae, femur, 
tibia and humerus.  Disruption of the cortices creates a stress riser in the bone, which can lead to 
compression fractures in the spine, or transverse and oblique fractures in long bones.   
 In a setting where an osseous tumor is discovered prior to pathologic fracture by X-ray, 
computed tomography (CT) or bone scintigraphy, treatment often involves surgical excision of 
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the lesion.  Debridement of a wide margin of bone accompanies excision of the lesion, in an 
attempt to remove the full extent of malignant or non-normal tissue.  Because of both the 
excision and debridement, the bone still remains susceptible to fracture through the original site 
of the tumor.  Extremely aggressive tumors can also compromise the integrity of a an entire 
region of bone, necessitating radical resection of entire sections of bone to prevent spread of 
malignancy.   
 In addition to surgical excision of the bone tumor, radiation and/or chemotherapy is 
frequently employed to reduce the size and viability of a tumor.  Post-operative radiation is often 
used to ensure that the, even when wide margin excision or resections are performed, the 
tumorous tissue will not return.  Radiation and certain types of chemotherapy have been shown 
to alter the biology within bone.  Further evidence exists which details the effect of radiation on 
local MSC populations in terms of their ability to differentiate towards an osteoblastic lineage 
and, ultimately, to repair bone.  Chemotherapeutic agents, such as methotrexate and Adriamycin 
have been shown to alter systemic bone formation dynamics, leading to an uncoupling between 
osteoclastic bone resorption and osteoblastic bone formation.  Georgiou, et al. demonstrated the 
effect of methotrexate on the differentiation capacity of marrow-derived MSCs in a rate model.  
In animals treated with methotrexate, MSCs were more likely to differentiate towards an 
adipogenic lineage, rather than an osteoblastic lineage.   
As described, the presence, as well as the treatment of osseous neoplasms results in a 
challenging clinical situation in terms of affecting bone healing.  The excision of a bone tumor, 
or resection of an entire section of bone creates a critical defect that necessitates the use of a 
bone graft construct to support biomechanical loading.  Pre- and post-operative radiotherapy 
and/or chemotherapy can have a negative effect on the potential of the patient to rapidly 
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regenerate bone at the site of excision.  As such, the bone graft employed must present a surface 
and morphology conducive to bone formation.  Additional agents, endogenous or exogenous, 
locally or systemically administered may be necessary to induce the rapid formation of bone at 
the grafting site. 
Hariri, et al recently described the use of a free vascularized fibular graft for 
reconstruction of metadiaphyseal bone of the femur and tibia following resection for expansile 
neoplasms, such as Ewing’s sarcomas (Hariri et al., 2010).  The graft was harvested from the 
fibula on the same side as the femur affected by the tumor.  This type of graft provides excellent 
load bearing support, due to the high ratio of cortical to cancellous bone.  In addition to load 
bearing support, this graft also contains fresh vascular tissue, which aids in the formation of a 
callus.  Callus formation precedes new bone formation due to the high concentrations of 
osteoinductive proteins and chemotactic agents for MSCs (Day, 2000)    
Bone Grafts for Spine Fusion 
Spinal arthrodesis, also known as spinal fusion, is a procedure which relies on the 
creation of a bony bridge between adjacent vertebrae, as shown in Figure 3.  Spine fusion is 
indicated for the treatment of both acute and chronic conditions of the spine, such as 
intervertebral disc herniation, degenerative disc disease, spondylolisthesis and 
spondyloarthropathy (DePalma et al., 1972; Hu and Bohlman, 1994; Malloy and Hilibrand, 
2002).  These conditions most often involve impingement of neurovascular structures by 
herniated intervertebral disc tissue, or vertebrae which have translated too far in relation to 
adjacent vertebrae.  Patients experiencing this impingement may present clinically with radiating 
pain (radiculopathy) throughout an extremity, numbness, tingling, loss of motor function and 
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even cognitive deficits (DePalma et al., 1972).  Other patients will present with debilitating axial 
back pain, which is confined to the midline of the spine without any radicular symptoms. 
 
                           
Figure 3.  Illustration of common intervertebral disc pathology leading to pain and 
dysfunction (right) and the technique of interbody fusion (right).  Image taken from 
www.orthogate.com/spine. 
 
Treatment of the symptomatic spine level involves the formation of a bony bridge 
between adjacent vertebrae.  The spine level is fused to restore the normal lordotic or kyphotic 
curvature of the spine, while increasing stability of the segment, thus reducing the incidence of 
future compromise of neurovascular structures, pain and dysfunction.  In the case of interbody 
fusion, arthrodesis is created between the vertebral bodies of adjacent vertebrae (DePalma et al., 
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1972).  This procedure involves making an incision to the outer annulus fibrosus of the 
intervertebral disc.  Once access is gained through the annulus fibrosus, the nucleus pulposus and 
inner annulus fibrosus tissue is removed by rongeurs and suction.  The endplates of the vertebral 
bodies within the intervertebral disc space are decorticated to yield bleeding bone, which 
theoretically aids in the migration of mesenchymal stem cells from the marrow cavities in the 
vertebral body.  Bone graft material is then placed between the vertebral bodies to maintain 
distance between vertebrae (disc height) and to induce and/or facilitate the growth of new bone, 
thus stabilizing the spine segment, as shown in Figure 4.  Depending on the technique used, a 
metallic plate may be placed in the anterior portion of the spine to prevent extrusion of the bone 
graft material, which, in the case of interbody fusion of the cervical spine, could cause damage to 
vital structures such as the trachea. 
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Figure 4.  X-ray of a patient who underwent cervical interbody fusion. 
In applications, such as interbody fusion, the bone graft material must be capable of 
withstanding substantial static compressive loads, as well as cyclic compression, bending and 
torsion (DePalma et al., 1972; Lippman et al., 2004; Shikinami and Okuno, 2003).  While the 
biomechanical loading within the long bones of the extremities and in the spine are significant, 
the mechanical properties of the bone graft should not exceed that of native bone.  Specifically, if 
the elastic modulus of a bone graft material greatly exceeds the elastic modulus of the bone that 
it is replacing, a phenomenon known as stress shielding may occur.  Stress shielding is the result 
of ineffective load transmission to growing bone, due to the mismatch in static mechanical 
properties.  Stress shielding renders bone growth slow and random according to Wolff’s Law and 
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frequently results in the formation of fibrous tissue, which is not conducive to load bearing 
(Shikinami and Okuno, 2003).   
In addition to the mechanical requirements of a bone graft material, numerous basic and 
translational science studies have described the importance of bone graft porosity.  
Interconnected pores with an average diameter of 250 m have been shown to facilitate cellular 
infiltration and neovascularization, which are critical components to bone growth (Georgiou et 
al., 2007; Kruyt et al., 2004; Mathieu et al., 2005).  Appositional bone growth, such as that which 
occurs on the outside edges of a dense construct, is not capable of bearing the high compressive 
loads in long bones of the extremities or in the spine.  A final requirement of a bone graft 
material is the ability to induce bone formation; a property referred to as osteoinductivity (Buck 
et al., 1989; Fini et al., 2004; Malloy and Hilibrand, 2002; Wigfield and Nelson, 2001; Wimmer 
et al., 2001).  In biologic materials, this property is mediated by endogenous biomolecules (i.e. 
growth factors) and pluripotent cells.  The process of osteoinduction begins with chemotactic 
recruitment of progenitor cells and the subsequent differentiation of these cells to an osteoblastic 
lineage.  The differentiated cells then form a collagenous matrix, which is subsequently 
mineralized resulting in the formation of bone. 
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CHAPTER 2:BONE GRAFT MATERIALS - FROM AUTOLOGOUS TO SYNTHETIC 
Background 
Bone grafting was first attempted and reported in 1668 in the Netherlands by Dr. van 
Meekeren.  This surgeon described the repair of a soldier’s traumatic cranial defect with bone 
harvested from a canine skull.  Nearly 250 years later, Dr. Albee described the use of autologous 
bone harvested from the lower extremity in achieving successful spine fusion.  Later that century 
as autologous bone grafting gained popularity, surgeons began attempting to isolate the growth 
factors from harvested bone to enhance fracture healing.  Dr. Urist, in 1965, was the first to 
isolate bone morphogenetic proteins from bone and later described the process by which these 
proteins led to bone formation by a process he termed “autoinduction.”   
The technique of bone grafting is now an extremely common adjunctive procedure 
performed in a variety of surgical scenarios to ensure rapid, complete healing of injured, or 
pathologically compromised bone.  Today, more than 1 million procedures are performed 
annually in the United States which involve the use of bone graft materials.  A sizeable market 
now surrounds bone graft and bone graft substitute materials, which generates in excess of $2.5 
billion in sales per year.  These numbers are continuing to climb as the average life expectancy 
of humans increase while simultaneously, the average age of orthopaedic patients decreases 
creating an ever-increasing demand. 
Despite significant progress in the techniques and materials used for bone grafting, as 
well as the increasing frequency with which these procedures are performed, there is still a 
substantial amount of room available for improvement.  Regardless of the use of cutting-edge 
recombinant human proteins and novel material processing methods, non-union (failure of bone 
formation) still persists as a common complication associated with bone grafting.  A comparison 
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of currently used materials, from biologic to synthetic, is presented with the intention of 
identifying the multi-factorial requirements of bone graft materials, advantages with specific 
clinically-used constructs and disadvantages which lead to clinical failure.  Since the focus is on 
bone graft materials used strictly for structural or load bearing applications, the discussion of 
various types of bone graft materials is focused nearly exclusively on graft materials used in 
spine fusion procedures. 
Requirements of Bone Graft Materials 
The mechanical strength of bone graft materials, is of primary importance as these 
constructs are meant to replace sections of bone damaged by trauma or biochemically altered by 
pathology.  Initial mechanical properties of the construct must be sufficient to support both static 
and dynamic loading in a variety of configurations, including compression, bending and torsion.  
Depending on the anatomic location, compressive loading in a long bone of the lower extremity 
can exceed several times body weight for common activities of daily living, such as jumping, 
walking down a flight of stairs and running (Day et al., 2000; Keaveny 1993). While it is 
important for the bone graft constructs to support biomechanical loading by possessing adequate 
mechanical properties, it is equally important that the stiffness, or modulus of the material does 
not greatly exceed that of the bone that the construct is attempting to replace.  When a material 
with an elastic modulus that greatly exceeds that of the host bone is implanted, a process known 
as stress shielding is likely to occur.  Stress shielding is a phenomenon that results in new bone 
formation being slowed and random, in terms of its structure.  Both new bone formation, as well 
as bone remodeling require the adequate transmission of load to the cells responsible for forming 
the tissue.  If a bone graft construct has an elastic modulus that greatly exceeds that of the bone it 
is replacing, the construct itself absorbs the vast majority of the biomechanical loading without 
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effective transmission to the newly forming bone.  According to Wolff’s Law, bone growth 
happens in a manner proportional to the stresses and strains that the bone experiences (Day et al., 
2000).  Without effective load sharing between the bone graft material and host bone, newly 
formed bone will be incapable of supporting biomechanical loads and will most often take on a 
fibrous appearance.  Stress shielding often requires a revision procedure to correct the problem 
(Day et al., 2000; Keaveny 1993). 
Constructs used as bone graft substitute materials should also possess characteristics 
conducive to their controlled resorption in vivo.  A goal of bone grafting is to use a construct as a 
temporary load bearing structure and scaffold for new bone formation.  The bone graft material 
is intended to be eventually replaced by host bone.  The temporary nature of a bone graft 
construct obviates the problems associated with permanent devices, which include an 
omnipresent risk of infection.  Additionally, permanent constructs, depending on their 
composition and properties, may complicate future surgeries that the patient may need.  For 
instance, the presence of a large synthetic scaffold used to heal a femur fracture, may create a 
difficult obstruction to the proper placement of a total hip replacement component that the 
patient may need several years later.  Non-resorbable materials used for bone graft application 
may also interfere with radiographic imaging, which is used to assess healing post-operatively. 
An obvious goal of bone grafting is to encourage new bone formation.  Autograft has the 
capability of inducing new bone formation, a process known as osteoinduction, due to 
endogenous growth factors and mesenchymal stem cells (MSCs).  This process was first 
described by Urist, et al. who examined bone formation due to “autoinduction” following 
implantation of demineralized bone matrix (Urist, 1965).  This group identified endogenous 
growth factors, such as bone morphogenetic protein-2 (BMP-2), transforming growth factor-beta 
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(TGF-) and platelet-derived growth factor (PDGF) as some of the main proteins involved in the 
process.  These proteins are chemotactic for mesenchymal stem cells.  Once recruited to the site, 
the MSCs begin to differentiate towards an osteoblastic lineage.  A collagenous extracellular 
matrix is deposited and subsequently mineralized by host osteoblasts, as well as recently 
differentiated MSCs.  Currently, recombinant technology is used to synthesize human BMP-2 
and BMP-7 for the purposes of enhancing bone formation following fracture or in the setting of 
spine fusion.  These growth factors can be used to confer the attribute of osteoinductivity to bone 
graft materials of all types, including synthetic constructs.  Another method used to encourage 
bone formation is the use of bone marrow aspirate.  Bone marrow is known to contain MSCs, as 
well as a complex milieu of biochemical factors that are capable of inducing bone formation.  
The use of bone marrow aspirate is accomplished via a needle biopsy of an anatomic location 
known to contain a significant volume of bone marrow and marrow-derived MSCs.  The iliac 
crest, vertebral bodies and proximal humerus are common locations for harvesting bone marrow 
aspirate.  The aspirate is then applied to the site of intended bone formation.Numerous clinical 
and pre-clinical trials exist outlining the success of these osteoindutive techniques.  
The property of osteoconductivity is another important requirement of bone graft 
materials.  This attribute refers to the ability of a construct to facilitate, rather than induce, new 
bone formation.  Numerous factors contribute to the development of osteoconduction of a 
material.  Scaffold materials should be porous to facilitate cellular infiltration within the three 
dimensional structure of the graft.  If cells are unable to penetrate a construct, appositional bone 
growth may occur.  Appositional bone growth is the generation of a ring of bone that forms 
along the outside of the graft constructs, rather than throughout the entire load bearing structure.  
Appositional bone growth is insufficient to support biomechanical loads, especially when the 
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graft material is designed to resorb over time in vivo.  If bone is to grow throughout the three 
dimensional structure of a graft construct, there must be a method to facilitate nutrient transport 
to the center of the graft to keep cells healthy and to continue the process of bone formation and 
maturation.  Nutrient transports is accomplished by the generation of microvasculature at the site 
of bone healing.  An average pore size of 100-300 m has been shown to be adequate to support 
the development of neovascularization and efficient microvascular infiltration of three 
dimensional constructs.  In addition to a porous microstructure, surface chemistry and 
topography of the scaffold has also been shown to be an important contributor to osteoblast 
attachment and proliferation.  surfaces promote osteoblas 
Autologous Bone Graft 
Autogenous iliac crest bone graft, shown in Figure 1, has been used extensively in 
cervical, thoracic and lumbar interbody spine fusion procedures with a high degree of clinical 
success.    Despite the success rate of the spine fusion procedures, harvest of autograft bone is 
associated with numerous harvest site complications (Buck et al., 1989; Hu and Bohlman, 1994; 
Malloy and Hilibrand, 2002; Samartzis et al., 2005; Wigfield and Nelson, 2001; Wimmer et al.,  
1999; Zdeblick and Ducker 1991).  Donor site complication rates as high as 20-30% have been 
reported after performing iliac crest graft harvest procedures (Hu and Bohlman, 1994; Malloy 
and Hilibrand, 2002; Wigfield and Nelson, 2001).  An iliac wing fracture rate of 7% was 
reported by Hu and Bohlman when harvesting for spinal fusion procedures (Hu and Bohlman, 
1994).  Even if the patient does not present postoperatively with symptoms of donor site 
morbidity, fracture initiating from the harvest site, or infection, DePalma and others found that 
the incidence of pain after iliac crest graft harvest was as high as 36% (DePalma et al., 1972).  
 28 
 
 
Exposure of the patient to this additional procedure of graft harvest also increases the likelihood 
of infection. 
 
Figure 1.  Anterosuperior harvest location for iliac crest bone graft. American Journal of 
Sports Medicine. 
 
Allogenic Bone Graft 
Due to the high rates of post-operative complications associated with the harvest of 
autograft bone, allogenic bone (allograft) has been proposed as an alternative (Malloy and 
Hilibrand, 2002; Samartzis et al., 2005; Wimmer et al., 1999).  Allograft is bone harvested from 
a donor, usually at the time of death.  The bone is aseptically harvested from the donor, sterilized 
and stored in a freeze-dried state in a tissue bank.  A number of reports in the literature have 
shown an increase in the use of allograft in spinal fusion applications.  In 1991, Zdeblick and 
Ducker experienced only a 78% rate of cervical arthrodesis when using allograft, as compared to 
92% who received autograft (Zdeblick and Ducker, 1991).  Similarly, Nugent and Dawson 
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reported a lumbar fusion rate of only 70% with allograft, compared to 92% with iliac crest 
autograft (Nugent and Dawson, 1993).  Recently, fusion procedures implementing allograft have 
achieved rates of fusion comparable to those using autograft.  In 2005, Samartzis and others 
achieved a 100% rate of cervical arthrodesis with allograft.  They found no statistically 
significant difference in the fusion rates between allograft and autograft (Samartzis et al., 2005).     
Functional outcomes are also slightly higher for allograft groups due to the elimination of harvest 
site complications associated with autograft harvest.   
However, numerous disadvantages of allograft usage exist.  While careful donor 
screening and sterilization procedures have reduced the incidence of disease transmission, 
reports still surface.  Specifically, the transmission of Hepatitis and HIV associated with allograft 
bone have been reported in the literature (Buck et al., 1989).  Additionally, the same sterilization 
procedure that reduces the risk of disease transmission has also been shown to reduce the 
osteoinductivity of the graft (Malloy and Hilibrand, 2002; Samartzis et al., 2005; Wigfield and 
Nelson, 2001).  Sterilization methods, such as gas plasma, ethylene oxide and gamma irradiation 
have been shown to have an effect on the concentration and efficacy of osteoinductive proteins 
endogenous to allograft.  Denaturation of these proteins compromises the ability of allograft 
bone to induce desired bone formation.  In addition to reduced osteoinductivity, allograft bone is 
subject to the finite supply of donor tissue.  Tissue banks in the European Union, as well as the 
United States have reported shortages of allograft tissue (Wigfield and Nelson, 2001; Wuisman 
and Smit, 2006; Zdeblick and Ducker, 1991).  Further, allograft is much less available in rural 
and geographically isolated hospitals. 
Clinically-Used Bone Graft Substitutes 
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Among the first substitutes explored were the calcium phosphates, particularly 
hydroxyapatite.  Hydroxyapatite (HA) is a ceramic material that is compositionally similar to 
native bone mineral, with a calcium to phosphorus ratio of 1.67.  HA that is currently in use is 
derived from sea coral, which is composed of calcium carbonate (Suetsuna et al., 2001; Zdeblick 
et al., 1994).  The calcium carbonate undergoes a hydrothermal conversion to HA.  The end 
result is a highly interconnected porous structure that compositionally and morphologically 
mimics cancellous bone.  Coralline HA has been used clinically in interbody spinal fusion 
procedures.  While corraline HA is an effective osteoconductive scaffold, it lacks the 
osteoinductive potential of autograft and allograft, which has resulted in inferior performance.  
Further, complications associated with fracture of the brittle ceramic have been reported.  These 
brittle failures result in reduced intervertebral disc height and subsequent compromise of 
neurovascular structures, necessitating immediate revision surgical procedures (Suetsuna et al., 
2001; Zdeblick et al., 1994). 
Calcium phosphates have also been used in particulate form for spinal fusion procedures.  
Several phases of particulate calcium phosphates are in current clinical use, including beta-
tricalcium phosphate (-TCP), HA and dicalcium phosphate dihydrate (DCPD).  The porosity, 
surface chemistry and composition have been shown to facilitate bone growth.  However, the 
particulate materials lack load-bearing capacity and therefore must be used with additional 
instrumentation, such as fusion cages.  These cages act as the load bearing component and also 
facilitate containment of the calcium phosphate material.  The mechanical properties of these 
cages, specifically the modulus of elasticity, exceeds that of native bone.  This results in the 
previously mentioned phenomenon of stress shielding, which renders bone growth slow and 
random.   
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To address the brittle nature of coralline HA and the non-load bearing capacity of 
particulate calcium phosphates, porous metal constructs have recently been introduced (Wigfield 
and Nelson, 2001).  The metallic constructs are fabricated using a number of different 
techniques, all resulting in the formation of highly porous structures resembling the architecture 
of cancellous bone.  The metals used, including tantalum, pure titanium and titanium alloys, have 
mechanical properties that make them capable of withstanding physiologic loading.  The open 
porous morphology of the construct decreases the bulk elastic modulus, reducing the incidence 
of stress shielding with these metals.  However, these porous metal constructs have not found 
great clinical acceptance in spine fusion procedures.  The non-resorbable nature of metals 
presents an omnipresent risk of infection to the patient.  Non-resorption also limits the options of 
a surgeon who is performing a revision procedure on the patient.  Metallic constructs also present 
a challenge to imaging modalities, such as computed tomography (CT) and magnetic resonance 
imaging (MRI).  The radiopacity of metals, can also reduce the accuracy of radiographic 
assessment of bone growth and fusion. 
Collagen-based sponges have shown a great deal of promise recently as bone graft 
substitute materials (Wigfield and Nelson, 2001).  These sponges are composed primarily of 
bovine type I collagen and may (HEALOS, Depuy Spine; CRM, Medtronic Inc.) or may not 
(INFUSE, Medtronic Inc.) be reinforced with calcium phosphates.  Collagen sponges have a 
fibrous structure with a high degree of interconnected porosity and are completely resorbablein 
vivo.  These constructs have been used in spine fusion, primarily for the delivery of 
osteoinductive growth factors, such as recombinant human bone morphogenetic protein-2 and -7 
(rhBMP-2, rhBMP-7 or OP-1).  While the growth factor-collagen sponges constructs have 
enjoyed widespread success, they still lack the ability to support biomechanical loading as a 
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standalone implant.  As such, they must be used in conjunction with permanent hardware, such 
as titanium or poly ether ether ketone (PEEK) fusion cages.  
Resorbable Polymers as Emerging Candidates for Bone Graft Substitute Applications 
Resorbable polymers, such as poly-L-lactic acid (PLLA) and poly-L-glycolic acid 
(PLGA), have been investigated for use as bone graft substitute materials (Georgiou et al., 2007; 
Kruyt et al., 2004; Mathieu et al., 2005; Tsuji et al., 2003; van Dijk et al., 2003).   While not 
currently used for this application clinically, these materials have shown excellent 
biocompatibility and resorb predictably in vivo.  Degradation is dominated by hydrolytic 
cleavage of ester linkages in the polymer backbone.  The byproducts of degradation are lactic 
and/or glycolic acid, which are easily metabolized in vivo to pyruvate, water and carbon dioxide.  
Controlled degradation of the polymer has been shown to facilitate slow release of therapeutic 
substances, such as growth factors used to induce bone formation.    
As previously stated, an interconnected porous morphology is a requirement of bone graft 
substitute materials.  The porous morphology supports cellular infiltration and nutrient transport 
affected by neovascularization.  Numerous methods have also been shown to be effective in 
synthesizing porous constructs from PLLA and PLGA polymers, including thermal-induced 
phase separation, particulate leeching and three dimensional free-form fabrication techniques.  
These techniques require the use of volatile organic solvents, such as chloroform or 
dichloromethane, to dissolve the polymer.  Even after several hours under vacuum, residual 
levels of organic solvent persist within the material.  These solvents leech from the construct 
when it is placed in an aqueous environment and can induce an inflammatory response.  
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Evidence also exists supporting the claim that organic solvent content can also induce a cytotoxic 
response, both in vitro and in vivo. 
Despite all of the potential benefits of resorbable polymer constructs, limited mechanical 
strength, especially of porous constructs, has kept PLLA and PLGA from clinical use in 
structural bone graft substitute applications.  Numerous filler materials have been investigated as 
agents to mechanically reinforce porous resorbable polymer matrices.  Calcium phosphates 
including HA and -TCP have shown efficacy in increasing the mechanical strength of porous 
PLLA and PLGA constructs.  Calcium phosphates also increase bioactivity of the constructs, by 
enhancing osteoblastic adhesion and differentiation.  Single and multi-walled carbon nanotubes 
have also been used to reinforce porous PLLA and PLGA constructs. Despite the numerous filler 
materials investigated to reinforce the mechanical properties of porous resorbable polymer 
matrices, compressive strengths of these constructs are still below the threshold required for 
spine fusion applications.  This lack of reinforcement efficacy has been attributed to poor filler-
polymer matrix interaction.  It has also been observed that current techniques employed to 
disperse fillers in resorbable polymers are not able to overcome the agglomeration of small 
particles.  Agglomerated particles within a polymer matrix lead to reduced mechanical 
properties.  Additionally, a lack of positive interaction between the polymer chains and the filler 
particles results in poor restriction of polymer chain mobility, which is a necessary component of 
reinforcement in polymer matrix composites.   
Resorbable polymer nanocomposites demonstrate a significant amount of promise as 
bone graft substitute materials.  To overcome current challenges associated with nanocomposite 
technology, a novel material formulation and synthesis route is needed.  The proposed method 
must ultimately result in a resorbable construct with an interconnected porous morphology, 
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which is capable of supporting new bone formation, as well as withstanding biomechanical 
loading. 
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CHAPTER 3:  POLYMER-MONTMORILLONITE CLAY NANOCOMPOSITES 
Background 
Resorbable polymers show promise as potential materials for use as synthetic bone graft 
substitute materials.  Their predictable degradation in vivo and track record of biocompatibility in 
multiple forms speak to this promise.  Unfortunately, the mechanical properties of resorbable 
polymers with a porous morphology are not sufficient for load bearing applications in the human 
spine or long bones of the extremities.  Due to this poor mechanical behavior, there is significant 
interest in developing a composite material.  Successful creation of a composite material would 
still allow physicians to take advantage of the desirable physical and chemical properties of the 
polymer, while reinforcing the matrix with a functional filler material.  Further, since bone is 
essentially a composite material (collagen matrix reinforced by hydroxyapatite) it is logical to 
replace that tissue with a synthetic composite material.  Nanocomposites consisting of a 
polymeric matrix reinforced by layered silicate fillers are a strong candidate for bone graft 
substitutes.  Specifically, lactic or glycolic acid-based polymers reinforced with organically 
modified Montmorillonite clays (nanoclay) are promising options for this biomedical 
application.  The exceptional improvements in mechanical properties associated with loading 
polymer matrices with nanoclays have stimulated a significant amount of research for non-
biomedical applications, as well. 
Structure of Montmorillonite Clay 
 Montmorillonite clays are naturally-occurring layered aluminosilicate minerals that are 
the main constituent of Bentonite, which is found in volcanic ash.  The structure of the clay is 
characterized by an octahedral sheet sandwiched by two tetrahedral sheets.  The octahedral sheet 
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is composed primarily of aluminum oxide, while the tetrahedral sheets are primarily silicon 
oxide (Pavlidou and Papaspyrides, 2008).  Aluminum atoms within the octahedral sheet can be 
substituted with other cations, which require a positive charge to balance the structure.  This 
positive charge often comes in the form of an alkaline earth cation (most often Na
+
, in 
Montmorillonite), which reside on top of the tetrahedral sheet (Ray and Okamoto, 2002).  The 
thickness of a single layer of Montmorillonite is approximately 1 nm, while the width can vary 
from 30 nm to several microns, giving the clays an extremely high aspect ratio and thus a very 
high reinforcement capacity in polymer matrices.  As is the case with many aluminosilicates, the 
tetrahedral-octahedral-tetrahedral structure repeats to form a layered structure with a regular van 
der Waals gap between layers, referred to as the gallery spacing (Pavlidou and Papaspyrides, 
2008).  Clays can be organically modified to increase the spacing between layers via ion 
exchange with cationic surfactants, such as alkyl ammonium salts.  The increase in intergallery 
spacing improves the dispersion of nanoclay within polymeric matrices and reduces the 
likelihood of particle agglomeration, which can negatively impact mechanical behavior (Horsch 
et al., 2006). 
Polymer-Clay Nanocomposites 
Polymer-nanoclay nanocomposites were first introduced by Toyota in the 1990’s and 
were based on Nylon-6 reinforced with unmodified Montmorillonite clay (Pavlidou and 
Papaspyrides, 2008; Ray and Okamoto, 2002).  Numerous processing methods exist to disperse 
natural and organically modified Montmorillonite clays within polymer matrices.  Regardless of 
the method, the overall goal remains the same: maximize polymer nanoclay interaction to reduce 
polymer chain mobility, thus enhancing static and dynamic mechanical properties.  In order to 
maximize polymer-clay interaction, processing methods are aimed at delaminating the layered 
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silicate structure into individual clay platelets (1 nm x 30 nm), which are subsequently dispersed 
in a random orientation throughout a polymer matrix.  Delamination and dispersion of the 
layered structure of clay is accomplished by infiltration of the intergallery space by polymer 
chains. Infiltration of polymer chains may be significant enough to cause delamination of the 
layered structure resulting in individual clay platelets dispersed throughout the matrix.  Increased 
motion of the polymer chains within the intergallery space during high-shear mixing may also 
encourage delamination and dispersion of clay platelets. 
There exists three different classes of polymer-layered silicate nanocomposites, which are 
based on the extent of dispersion of clay platelets in the polymer.  The first type is known as an 
intercalated nanocomposite and is characterized morphologically by infiltration of polymer 
chains within the intergallery space of the clay.  The infiltration of the polymer increases the 
intergallery spacing of the clay, but does not result in delamination of the layered structure.  
Intercalated morphologies lend themselves to both strong polymer-clay interaction, as well as 
considerable nanoclay-nanoclay interaction since the layered structure has not become 
completely delaminated.  Intercalated nanocomposites typically exhibit a high elastic modulus 
(tensile), significantly reduced ultimate strength and improved fracture toughness.  The 
improvement in fracture toughness is thought to be related to the increased surface area, 
associated with intercalated morphologies.  A second class of nanocomposites, which is closely 
related to the intercalated morphology, is termed flocculated.  Similar to intercalated 
nanocomposites, polymer chains have infiltrated the intergallery space, but have not resulted in 
platelet delamination and subsequent dispersion.  The main difference between intercalated and 
flocculated nanocomposites is the interaction between whole clay particles within the polymer 
matrix.  In flocculated nanocomposites, clay particles, each consisting of a layered structure, 
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interact with each other leading to flocculation or agglomeration of the particles within the 
matrix.  Interaction between clay particles is mediated by the hydroxylated silicate layers.  
Flocculated nanocomposites have mechanical property changes similar to that of intercalated 
nanocomposites, but tend to have lower ultimate strength and stiffness.  These similarities arise 
from the fact that there is still significant infiltration of polymer chains within the layered 
structure of the nanoclay.  However, flocculation of the particulate within the polymer matrix 
often leads to significant variation in properties due to non-uniform dispersion of the clay within 
the matrix.  Non-unifiorm dispersion is attributed to nanoclay-nanoclay interaction, which leads 
to the development of clay-rich and clay-poor regions of a nanocomposites construct.  The final 
class of nanocomposites is the exfoliated structure.  This morphology is characterized by clay 
particles with layered structures that have been completely delaminated and dispersed at random 
throughout the polymer matrix, as shown in Figure 1.  In exfoliated nanocomposites, polymer 
chain infiltration and subsequent interaction overcome platelet-platelet attraction resulting in 
complete delamination and dispersion of individual clay platelets throughout the matrix.  
Exfoliated nanocomposites typically exhibit significant increases in both static and dynamic 
mechanical properties, even at low clay loading levels.  Exfoliated nanocomposites do not 
exhibit as significant of improvements in fracture toughness when compared with intercalated 
nanocomposites.  However, the random orientation of individual clay platelets within the 
polymer matrix does result in toughening compared to native polymer structures.  
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Figure 1.  Illustration of clay platelet morphology in intercalated (A), intercalated-flocculated 
(B) and exfoliated (C) polymer-clay nanocomposites. 
Supercritical CO2 Processing of Polymer-Clay Nanocomposites 
To achieve the various morphologies of polymer-clay nanocomposites, a number of 
processing methods have been employed including in situ polymerization, melt intercalation, 
extruding and solvent processing (Pavlidou and Papaspyrides, 2008; Ray and Okamoto, 2002). 
Another method of processing exists, which utilizes supercritical carbon dioxide as the solvent 
for processing (Horsch et al., 2006; Manitiu et al., 2008).  Supercritical carbon dioxide (scCO2) 
processing is technique that is growing in popularity in terms of its use in the creation of 
polymer-clay composites.  scCO2processing involves mechanical mixing of nanoclays with 
polymers.  The subsequent mixture is poured into a mold and placed inside of a sealed, high-
pressure reactor vessel.  The vessel is then filled with CO2 from a high pressure source.  The 
internal temperature and pressure of the vessel is then elevated to bring the CO2 to the 
supercritical region of the temperature-pressure phase diagram.  In this region, CO2 has the 
excellent mass transfer characteristics, as simultaneously possesses the density of the liquid state 
and diffusivity of the gas state.  Elevation of the CO2 to the supercritical region also increases the 
solubility of many polymer systems.  During saturation and subsequent temperature-pressure 
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elevation, the polymer becomes solvated within the reactor vessel.  CO2 also diffuses into the 
intergallery region of the clay particles, as solvated polymer chains also infiltrate the layered 
structure.  After a specified duration of exposure to the supercritical fluid, the reactor vessel is 
rapidly depressurized, inducing a thermodynamic instability within the polymer-clay mixture.  
Rapid CO2 bubble nucleation and growth, as well as polymer chain infiltration, delaminate the 
layered structure of the nanoclay and uniformly disperse the filler throughout the matrix (Horsch 
et al., 2006; Manitiu et al., 2008). 
 
Proposed Use of scCO2 Processing to Create Synthetic Bone Graft Substitute Materials 
While scCO2 processing has been used primarily in the synthesis of polymer 
nanocomposites for automotive and textile applications, it may be useful in the development of 
synthetic bone graft substitute constructs (Baker et al., 2009; Baker et al., 2011).  The proposed 
material would be composed organically modified nanoclay dispersed in a poly-D-lactide 
(PDLA) matrix, with an interconnected porous morphology.  The hypothesized method of 
synthesis includes mechanical mixing of as-received, organically-modified Montmorillonite clay 
with particles of PDLA in a mold.  The mixture would be placed in a high pressure reactor 
vessel, and subjected to CO2 at elevated temperatures and pressures.  Following a specific 
duration of saturation, the system would be depressurized.  Catastrophic depressurization 
delaminates the layered platelet structure of the clay, as previously described.  In addition to 
delamination of clay platelets, CO2 bubble nucleation and growth will take place during 
depressurization.  As the structure solidifies, the coalescence of CO2 bubbles yields an 
interconnected porosity throughout the construct.  Both pressure of the composite material 
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expanding against the mold, as well as heat transfer characteristics of the mold will contribute to 
the formation of a dense shell, resembling the structure of cortical bone.  This shell will 
transition abruptly to a porous core, which resembles the interconnected porous morphology of 
cancellous bone.  The resulting construct will mimic the dense-porous morphology of cortico-
cancellous grafts used in structural bone grafting applications.  In vivo, it is proposed that the 
porous core will facilitate three-dimensional cellular infiltration by osteoprogenitor cells.  The 
average pore diameter will also be sufficient to support neovascularization that is necessary for 
nutrient transport throughout the construct.  The dense “cortical” shell of the construct will 
support biomechanical loading in a manner similar to cortico-cancellous bone graft. 
Supercritical CO2 processing has been used by other researchers to create porous 
polymeric scaffolds and even composite materials (Georgiou et al., 2005; Mathieu et al., 2008).  
Mathieu et al. synthesized poly(L-lactic acid) foams reinforced with calcium phosphate 
particulate.  From the same group, Georgeiou, et al. used scCO2 processing to create phosphate 
glass-reinforced porous PLLA constructs.  In both instances, considerable improvements in in 
vitro biologic response was observed.  However, both studies demonstrated only modest gains in 
static mechanical properties.  The authors attributed this to poor dispersion of the filler materials 
within the resorbable polymer matrix.  It is hypothesized that increased positive interaction 
between the polymer chains and filler material will result in improved dispersion, which should 
lead to uniform structural properties. 
A key aspect of the scCO2 process that makes it especially attractive for the application 
of creating bone graft substitutes is the ability to impart a porous morphology to the constructs.  
Pores in the construct arise from the nucleation of CO2 bubbles within the solvated polymer upon 
depressurization of the vessel.  In a pure polymer construct, the formation of pores follows a 
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classical homogenous nucleation model.  However, when processing nanocomposites, 
heterogeneous nucleation of CO2 bubbles dominates.  As described by Tomasko, the rate of 
heterogeneous nucleation can be described by classical heterogeneous nucleation theory, as 
described below: 
N = f1C1exp[-G
*
het/kT]               [1] 
where f1 is the gas frequency factor and C1 is the concentration of nucleation sites.  For the 
purposes of a polymer-clay nanocomposite processed by scCO2, C1 is proportional to the 
concentration of clay platelets within the polymer.  In this Ahrennius eqution, k is also the 
Boltzmann constant and T is absolute temperature.  The Gibb’s free energy of heterogenous 
nucleation (G*het) is a function of the interfacial tension between the supercritical fluid and 
polymer-clay mixture (), supersaturation of the mixture with CO2 (P = Psaturation – Pactual) and 
the three component contact angle () at the polymer-clay-fluid interface.  G*het can be 
expressed as: 
 G*het = 16
3
f()/(3P2)               [2] 
 where, 
f() = ¼(2+cos)(1-cos)2               [3] 
From these equations (Eq. 1, Eq. 2 and Eq. 3), it can be seen that scCO2 processing parameters 
can play an important role in determining the porous morphology of bone graft substitute 
materials.  Specifically, the alteration of saturation pressure, processing temperature and 
effective clay concentration should have a significant effect on the rate of bubble nucleation.   
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The C1 term in Equation 1 actually shows a dependence of the nucleation rate on the 
dispersion of clay within the polymer matrix.  Fully exfoliated nanocomposites would have a 
higher concentration of nucleation sites, compared to intercalated, or intercalated-flocculated 
nanocomposite morphologies.  As Zeng, et al. found, an increased number of nucleation sites in 
well-dispersed PMMA-clay nanocomposites results in the formation of a material with a high 
degree of total porosity and pores with a small average diameter (Zeng et al., 2003).   
Supercritical CO2 processing is a promising method for the rapid synthesis of resorbable 
polymer-clay nanocomposites for bone graft substitute applications.  The process itself lends 
itself to a substantial amount of control over the resulting morphology and properties of the 
synthesized construct.  An additional benefit to utilizing scCO2 processing is the lack of harmful 
organic solvents during processing.  Since lactic acid polymers are very soluble in CO2, the use 
of chloroform and dichloromethane is no longer a concern. 
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CHAPTER 4:  STRUCTURE AND MECHANICAL PROPERTIES OF 
SUPERCRITICAL CARBON DIOXIDE PROCESSED POROUS RESORBABLE 
POLYMER CONSTRUCTS:  INFLUENCE OF POLYMER COMPOSITION AND 
PROCESSING PARAMETERS 
Introduction 
Currently, there are over 1 million surgical procedures performed annually in the United 
States that require the use of bone graft materials.  Spinal fusion, which is a surgical intervention 
used to alleviate nerve root impingement and restore spinal segmental stability, accounts for 
greater than 60% of bone graft material usage (www.aaos.org).  In interbody (or intervertebral) 
spinal fusion procedures, the gel-like nucleus pulposus is removed, the vertebral endplates are 
decorticated and a bone graft material is placed in the disk space between adjacent vertebrae.  
The role of the bone graft material is to facilitate bone growth and subsequent fusion between the 
adjacent vertebrae, while withstanding biomechanical loading.  For this reason, the highly 
porous, yet structurally stable bone harvested from the antero-superior portion of the patients’ 
iliac crest is considered to be the gold standard in achieving successful fusion (Samartzis et al., 
2005; Wimmer et al., 1999; Zdeblick et al., 1994). 
Despite the high clinical success surrounding the use of autologous iliac crest bone in 
spinal fusion procedures, the graft harvest procedure is not without risk.  Donor site complication 
rates as high as 33% have been reported in the literature and include an increased probability of 
iliac wing fracture, tissue necrosis and infection (DePalma et al., 1972; Hu and Bohlman, 1994; 
Samartzis et al., 2005; Wimmer et al., 1999).  Allogenic iliac crest has been used in place of 
autograft to reduce these complications, but has yet to attain comparable rates of fusion 
(Samartzis et al, 2005; Wimmer et al., 1999).   
Synthetic bone graft substitutes consisting of porous metals, or calcium phosphate-based 
ceramics have been introduced (Sidhu et al., 2001; Zdeblick et al., 1994).  While the architecture 
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of these substitute materials does accurately simulate the trabecular morphology of iliac crest, the 
fracture toughness of ceramic-based constructs is a concern with reports in the literature of 
subsidence and loss of disk space height (Sidhu et al., 2001; Zdeblick et al., 1994).  Porous 
metals are also not without disadvantage as they obstruct medical imaging studies and are a 
source of increased patient risk, due to device permanence (Lippman et al, 2004; Sidhu et al., 
2001; Wuisman and Smit, 2006). 
Resorbable polymers, which are currently in use in orthopaedic surgery, avoid the 
problems associated with permanent metallic constructs since the polymers degrade at a 
predictable rate in vivo (Lippman et al., 2004; Vacaaro et al., 2004; Wuisman and Smit, 2006).  
The radiolucency of the polymers also facilitates in vivo imaging without construct artifact 
(Lippman et al., 2004; Vacaaro et al., 2004; Wuisman and Smit, 2006).  Gradual dissolution of 
the polymers in vivo also guarantees that a significant percentage of the biomechanical loading 
will be transferred to de novo bone.  This load transmission is essential to bone growth and 
remodeling according to Wolff’s Law (Lippman et al., 2004; Samartzis et al., 2005; Sidhu et al., 
2001; Vacaaro et al., 2004; Wuisman and Smit, 2006). 
Resorbable polymer devices currently in use are not suited for bone graft applications due 
to the non-porous nature of their structure.  Numerous techniques have been explored in tissue 
engineering literature, which seek to synthesize resorbable polymer constructs with porous 
structures (Georgiou et al, 2007; Hu Y et al., 2001; Kim et al., 2007; Mathieu et al., 2005; Nam 
and Park, 1999; Teng et al., 2007; Wang Y et al., 2008; Zeng et al., 2003).   Phase separation 
processes, which involve the dissolution of a polymer in a volatile organic solvent and 
subsequent induction of a thermodynamic instability (i.e. rapid changes in temperature and/or 
pressure), have been used with success (Hu Y et al., 2001; Nam and Park, 1999; Wang Y et al., 
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2008).  Wang et al. recently reported success in using a collagen/PLA/hydroxyapatite composite 
fabricated by a freeze-drying method in the healing of a 15 mm segmental defect in the rabbit 
radius.   
Despite reported pre-clinical successes, there is a biological concern regarding the 
residual solvent content within the porous polymer structures.  Recently, supercritical carbon 
dioxide (scCO2) processing has been investigated as a biologically and environmentally friendly 
alternative to creating porous, resorbable polymer structures (Georgiou et al, 2007; Kim et al., 
2007; Mathieu et al., 2005; Teng et al., 2007; Zeng et al., 2003).  Several of the studies have 
examined the effects of process parameters and nanoparticle incorporation on the resulting 
structures.  To date, no literature exists which compares the architectural, mechanical and surface 
chemical properties of porous resorbable poly (lactic-co-glycolic acid) (PLGA) polymer 
constructs  prepared by scCO2 processing.   
Synthesis of porous, resorbable polymer constructs with differing lactide-to-glycolide 
ratios may aid in the development of bone grafts with tailored degradation kinetics and 
mechanical properties. An understanding of the interplay between processing parameters and 
polymer chemistry will lead to reproducible synthesis of polymer constructs with porous 
architecture approximating that of trabecular bone. Therefore, this study seeks to evaluate the 
effect of scCO2 processing parameters on the resulting architecture of porous, resorbable PLGA 
constructs with different glycolic acid contents.   Additionally, the effect of lactide-to-glycolide 
ratio on the resulting architecture, static mechanical properties and hydrophilic surface character 
will be characterized.   
 
Materials and Methods 
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Pure poly-D-lactide (100PDLA) and poly-D-lactide-co-glycolide with molar ratios of D-
lactide to glycolide of 85:15 (85:15PDLGA) and 65:35 (65:35PDLGA) were purchased from 
Lakeshore Biomaterials.  All polymers had intrinsic viscosities in the range of 0.40-0.60 dL/g 
and were terminated by ester groups.   
Polymers were ground to an average particle size of 250-500 m and placed in 20 mL 
borosilicate glass vials (28 mm O.D. x 61 mm H).  The vials restrict radial expansion of the 
polymer, but allow for expansion in the vertical direction.  The polymer-filled vials, each with 
2.0 g of ground polymer, were placed into a supercritical fluid reactor and saturated with CO2.  
The internal pressure was elevated to 10.3, 13.8, or 27.6 MPa at an internal temperature of 35
o
C, 
or 100
o
C to induce a supercritical phase transformation in the CO2.  After 20 minutes of soaking, 
the reactor was rapidly depressurized at a rate of 0.3-0.4 Mpa/s.  To examine the effect of 
confining the samples after processing, the glass vials were either broken immediately, or kept 
intact for 48 hours.   
Constructs were freeze-fractured with liquid nitrogen in the vertical (direction of CO2 
escape) and transverse (direction perpendicular to CO2 escape) directions.  Fracture surfaces 
were coated with a thin film of AuPd and subjected to scanning electron microscopy (SEM, 
JEOL JSM 6400, JEOL Ltd.).  SEM was performed at a working distance of 15 mm and an 
accelerating voltage of 20 kV.  Measurements of pore size and  pore wall thickness and 
assessments of pore interconnectivity were performed using digital image analysis software 
(Revolution, 4Pi Analysis).  Measurements were conducted on a minimum of three vertical and 
three transverse fracture surfaces.  At least eight images were taken from each fracture surface.  
Pore dimensions were measured for 20 pores per fracture surface image.   
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Mechanical testing was performed on samples with interconnected pores ranging in 
diameter from 150-250 m, which is similar to the architecture of iliac crest bone (Mosekilde 
and Mosekilde, 1982; Samartzis et al., 2005).  Cylindrical cores were removed from the 
specimens using a 10 mm diameter osteochondralautograft transplant system (OATS, Arthrex 
Inc.).  The sample areas cored were chosen to not include the dense cortical shell that was 
formed at the periphery of the foams during processing.  The cores were sectioned with a scalpel 
to a height of 10 mm.  Six samples from each co-polymer formulation were then subjected to 
axial compression in a servo-hydraulic material testing machine (850 Mini-Bionix Bi-axial, MTS 
Corporation).  Loading took place between lubricated, stainless steel platens at a rate of 0.5 
mm/min, as previously described (Georgiou et al, 2007; Mathieu et al., 2005).  The samples were 
compressed to a displacement equal to 50% of their original height.  This displacement was 
chosen because a loss of disk space height of this magnitude would represent a compromise of 
neurovascular structures (Zdeblick et al., 1994).  Compressive strength of the constructs was 
determined by dividing the peak load by the original cross-sectional area.  The compressive 
modulus was quantified by calculating the slope of the elastic region of the stress-strain curve.  
Elastic recovery of the samples was determined by measuring the height of the samples five 
minutes after mechanical testing.  The recovered height was divided by the original height and 
reported as a percentage of the original height.  
Water uptake experiments were performed on 10 mm x 10 mm cylinders sectioned from 
the same cores used for mechanical testing.  Five cylinders from each of the polymer 
formulations were initially weighed and subsequently immersed in deionized water.  The 
cylinders were removed from the water and weighed at 1, 2, 4, 8, 12 and 24 hours.  Prior to 
weighing, the samples were placed on absorbent towels for 5 minutes and subjected to 
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compressed air (145 psi, or 1.0 Mpa).  The overall change in mass was determined by dividing 
the difference between the new weight and the original weight by the original weight and 
multiplying by 100%.  Water uptake experiements are used frequently to assess the ability to 
load exogenous growth factors or autologous bone marrow aspirate into porous constructs.  
Additionally, water uptake experiments provide information about the ability of cells to penetrate 
a matrix.  Finally, water uptake experiments are a very bulk method to determing surface 
character of a materials.  The surface character and hydrophilicity of implant materials have been 
shown to influence osteoblast response (Baker et al., 2006; Bren et al., 2004).   
 
Results 
Effects of Processing Conditions and Polymer Composition 
Processing temperature was found to influence the pore size of scCO2 processed 
constructs (Figure 1, Table 1) with unconstrained radial expansion.  Samples processed at 35
o
C 
exhibited mean pore sizes of 238.0 m (+/- 4.83 m), with a few pores as large as 400 m in 
diameter.  Pore walls were 32.23 m (+/- 2.47 m) thick on average.  In contrast, the samples 
processed at 100
o
C had pore sizes that averaged 21.5 m (+/- 1.53 m), 17.03 m (+/- 2.33 m) 
thick pore walls and a very low extent of pore interconnectivity. 
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FIGURE 1.  SEM images of longitudinal fracture surfaces of 65:35PDLGA samples processed 
at 100
o
C (left) and 35
o
C (right) with a pressure of 13.8 Mpa and unconstrained radial 
expansion.   
 
TABLE 1.  Pore diameters and pore wall thicknesses of polymeric constructs as a function of 
temperature (unconstrained radial expansion). 
Polymer Average Pore Wall Diameter (mm) Average Pore Wall Thickness (mm) 
100 PDLA  
35
o
C – 2000 psi 236.2 ±4.8 32.1 ±1.1 
100
o
C – 2000 psi 22.3 ±1.3 17.4 ±3.5 
85:15 PDLGA  
35
o
C – 2000 psi 238.6 ±6.5 33.0 ±4.2 
100
o
C – 2000 psi 22.1 ±2.1 16.8 ±1.2 
65:35 PDLGA  
35
o
C – 2000 psi 239.3 ±3.2 31.6 ±2.1 
100
o
C – 2000 psi 20.1 ±1.2 16.9 ±2.3 
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Construct architecture was found to be nearly identical for samples processed at 10.3, 
13.8, 26.7 Mpa.  Processing samples at a higher pressure did not increase the pore diameters.  
Samples processed at a temperature of 100
o
C again showed an order of magnitude decrease in 
pore size, in comparison to samples processed at 35
o
C, regardless of pressure. 
Removal of the samples was accomplished by shattering the glass vials that contained the 
sample.  When samples were processed at a temperature of 35
o
C and were immediately removed 
from the vials, a rapid increase in sample volume occurred.  This volume change was not 
observed upon removal after 48 hours of confinement in the glass vials.  Confining the samples 
for 48 hours after scCO2 processing had an effect on both average pore size and pore 
interconnectivity (Figure 2).  Average pore diameters decreased to 183.9 m, 216.3 m and 
203.7 m for 100PDLA, 85:15PDLGA and 65:35PDLGA constructs processed at 35oC, 
respectively.  Confinement also increased the degree of interconnectivity of the constructs 
processed at 35
o
C, as observed by SEM.  Despite the fact that no method was employed to 
directly quantify interconnectivity, qualitative  characterization of construct architecture from 
SEM images revealed that constrained samples showed more open pores and pore-pore 
connections.  No changes in construct architecture due to confinement were observed for 
samples processed at 100
o
C, again demonstrating the importance of processing temperature.   
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FIGURE 2.  SEM images of longitudinal cross-sections of 85:15 PDLGA constructs 
unconstrained (left) and constrained (right) after processing. 
 
Supercritical CO2 processing of the resorbable polymers in glass vials results in the 
formation of a dense outer layer on the constructs, which is rigidly attached to the porous core 
(Figure 3).  It should be noted that the samples used in this study underwent mechanical testing 
without the dense outer layer intact.    
 
 
FIGURE 3.  SEM images of an iliac crest bone graft (left) and a 100PDLA construct showing 
similar porous morphology and “cortical” shell. 
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Mechanical Properties of Constructs 
Mechanical testing of the porous polymer constructs yielded information about the 
resulting static mechanical properties of the constructs.  Overall, 85:15 PDLGA had the highest 
compressive strength (4.35 +/- 1.78 Mpa) and compressive modulus (36.41 +/- 12.13), as shown 
in Table 2.  The compressive strength of 100 PDLA (3.40 +/- 0.54 Mpa) and compressive 
modulus (33.79 +/- 9.3 Mpa) were lower than that of the 85:15 PDLGA, but significantly higher 
than the compressive strength and modulus of 65:35 PDLGA (1.11 +/- 0.34 Mpa and 6.56 +/- 
4.04 Mpa, respectively).  Elastic recovery was greatest for the 65:35 PDLGA constructs 
(70.92%), followed by the 100 PDLA (63.84%) and 85:15 PDLGA constructs (61.89%). 
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FIGURE 4.  Representative compressive stress-strain curves from each of the co-polymer 
constructs, with varying PGA compositions.  Samples were processed at 35
o
C at a pressure of 
13.8 Mpa and constrained radial expansion. 
 
TABLE 2.  Static mechanical properties of porous resorbable polymer constructs synthesized by 
supercritical carbon dioxide processing.  Samples were processed at 35
o
C with a  pressure of 
13.8 Mpa and constrained radial expansion. 
 
 
Water Uptake Capacity of Constructs 
All constructs demonstrated a significant weight gain within the first two hours of 
immersion in deionized water (Figure 5).  The weight gains tapered off significantly after the 
first two hours as the polymer swelling began to approach equilibrium with the solution.  The 
100PDLA and 85:15PDLGA samples showed similar weight gains throughout the duration of 
immersion, while the 65:35PDLGA samples exhibited a much greater weight increase at all time 
points.  The 65:35PDLGA samples began to show a marked decrease in mass after 12 hours of 
immersion.  Hydrophilicity of the polymers increases with increasing glycolic acid content, 
which would enhance water uptake.  As such, it was expected that the 85:15PDLGA and 
65:35PDLGA samples would show larger changes in weight upon immersion.  The 100PDLA 
Polymer Elastic Recovery 
(% of original height) 
Compressive Strength 
(Mpa) 
Compressive Modulus 
(Mpa) 
100PDLA 63.84% ±4.02% 3.40 ±0.54 202.72 ±55.8 
85:15PDLGA 61.89% ±3.22% 4.35 ±1.78 218.43 ±72.76 
65:35PDLGA 70.92% ±10.42% 1.11 ±0.34 39.38 ±24.26 
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sample does show a slightly higher weight gain than the 85:15PDLGA, but there is a significant 
standard deviation in both of these sample populations. 
 
 
FIGURE 5.Graph showing the change in mass of the constructs as a function of duration 
immersed in deionized water. 
 
Discussion 
This study focused on the copolymer composition, mechanical behavior and 
hydrophilicity of porous, resorbable polymer constructs synthesized by supercritical CO2 
processing.  The influence of scCO2 processing parameters on construct microstructure (i.e. pore 
diameter, pore wall thickness and interconnectivity) was characterized by SEM, while 
mechanical compression testing elucidated the static mechanical properties.  Hydrophilicity and 
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potential for growth factor loading of the porous constructs was determined by water uptake 
assays. 
Pore structures of the constructs were significantly influenced by the processing 
temperature. This influence may be explained by the physical events that occur during scCO2 
processing.  When the polymer is soaked in scCO2 at elevated temperatures, significant swelling 
occurs.  During depressurization of the system, primary pore formation arises from the CO2 
bubble nucleation and growth.  The pore structure continues to evolve as a function of CO2 
escaping from the sample, which creates expansile, bi-axial flow in the polymer structure. The 
combination of the low processing temperature (35˚C) and the cooling due to CO2 expansion 
may reduce the sample temperature to below its glass transition during depressurization, even 
with the solvation effect of any residual CO2.  As the solidified sample warms up again, the 
residual trapped CO2 continues to try to expand resulting in larger pores for the unconfined 
construct. At 100˚C, the polymer is less viscous and the Joule-Thompson cooling due to rapid 
CO2 expansion is not sufficient to reduce the temperature below the glass transition temperature 
of the polymer.  Therefore, all of the CO2 has escaped upon depressurization, resulting in 
negligible expansion after releasing confinement.  The significant difference in pore size 
between constructs processed at 35˚C and 100˚C may be attributable to a nearly fourfold 
decrease in CO2 density at the higher temperature.  Alternatively, process pressure was not found 
to play a significant role in altering the pore structure of the resorbable polymer constructs, 
possibly due to the relatively insignificant difference in the density of the CO2 at the three chosen 
pressures.   
Constructs synthesized by the scCO2 process exhibited a porous core and a dense outer 
layer.  This morphology is similar to the structure of an iliac crest bone graft, which has a thin 
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cortical shell that surrounds the trabecular core (Mosekilde and Mosekilde, 1982; Samartzis et al, 
2005; Sidhu et al., 2001; Zdeblick et al., 1994).  The cortical shell of the iliac crest bone graft 
provides structural support during biomechanical loading.  It is hypothesized that the dense outer 
layer of the porous, PLGA polymer constructs would provide similar structural support.  The 
outlayer observed on the constructs is a function of the rapid diffusion of CO2 from the surface 
of the polymer construct.  In the center of the construct, CO2 escape is much slower allowing for 
the evolution of a porous structure.  Siripurapu et al. examined methods to encourage pore 
formation at the periphery of the constructs in an effort to reduce skin formation in PMMA 
porous-thin film applications.  Constraining the polymer limited the rapid diffusion of CO2 from 
the construct surface, which encouraged the nucleation and growth of pores at the construct 
surface, rather than a dense skin.  Increasing depressurization rate also increased cell density in 
this system.  In the present study, polymers were constrained in the radial direction and 
unconstrained in the vertical direction.  Lack of constraint in this direction likely facilitated rapid 
CO2 escape from the surface and subsequent formation of a dense shell on the constructs.  Again, 
for this specific application, a dense “cortical shell” is desired to enhance load bearing capacity. 
Pore interconnectivity is essential to the process of bone formation, which consists of 
cellular infiltration, neovascularization and nutrient transport (DePalma et al, 1972; Samartzis et 
al, 2005; Wimmer et al., 1999; Zdeblick et al., 1994).  Confining the samples for 48 hours after 
processing at 35
o
C decreased the average pore size and increased the pore interconnectivity of all 
constructs, regardless of glycolic acid content.  Radial expansion of the construct is limited by 
the diameter of the glass vial, which results in significant internal stresses.  These internal 
stresses limit pore diameter and lead to pore wall collapse, which results in interconnected pores.  
Immediate removal of the samples from the glass vials after processing leads to unconstrained 
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expansion in the radial direction.  Since there is no physical boundary to expansion, pores can 
grow with less risk of wall collapse.    
While the constructs showed similar architectures with the varying processing 
parameters, the different polymer blends exhibited variations in static mechanical properties.  
The mechanical compression testing of the constructs suggests that 85:15PDLGA and 100PDLA 
samples exhibit the significantly higher compressive strength and compressive moduli (Figure 4, 
Table 2) compared to the 65:35PDLGA.  These have compressive strengths of 4.35 Mpa (+/- 
1.78 Mpa) and 3.40 Mpa (+/-0.54 Mpa), respectively, which are comparable to cancellous bone 
found in veretebral bodies (Jensen et al., 1990; Mosekilde and Mosekilde, 1982).  The elastic 
moduli of the 85:15PDLGA and 100PDLA samples, 36.41 Mpa (+/- 12.13 Mpa) and 33.79 Mpa 
(+/- 9.30 Mpa) respectively, are significantly lower than the reported values of cancellous bone. 
The 65:35PDLGA samples had significantly lower compressive strength and compressive 
modulus of elasticity as compared to the 85:15PDLGA and 100PDLA samples.  A compressive 
strength of 1.11 Mpa (+/- 0.34 Mpa) and an elastic modulus of 6.56 Mpa (+/- 4.04 Mpa) suggest 
that the 65:35PDLGA porous constructs may be unsuitable for orthopaedic, load-bearing 
applications, such as that encountered by bone graft materials, unless a different type of construct 
is considered However, these results indicate that 85:15PDLGA and 100PDLA constructs may 
withstand biomechanical loads found in the cervical spine (Patwardhan et al., 2000).  The 
standard deviations of the compressive strength and elastic moduli values were significant, due 
to regional variations in pore architecture between samples.   
The recovery of sample height after the removal of the compressive load was similar for 
all samples, as shown in Table 2.  The 65:35PDLGA constructs showed a 70.92% (+/-10.42%) 
recovery of their initial height, five minutes after the removal of the load.  This value is 
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somewhat higher than the values reported for 100PDLA (63.84% +/-4.02%) and 85:15PDLGA 
(61.89% +/-3.22%).  This small difference may be attributed to the retention of some residual 
CO2 by the 65:35PDLGA constructs.  Recovery of construct height upon removal of the 
simulated biomechanical load is important in terms of maintaining disk space height (distance 
between vertebrae) in the spine (Zdeblick et al., 1994). 
The compressive strengths of resorbable polymer devices (dense) currently used in spine 
surgery far exceed that of the porous constructs presented in this study.  However, the porous 
morphology of the constructs achieved by scCO2 processing offers a distinct advantage over 
dense constructs, in terms of bone in-growth.  Pore sizes in the range of 200-250 m are essential 
for neovascularization of the graft and subsequent nutrient transport (DePalma et al., 1972; 
Samartzis et al., 2005; Wimmer et al., 1999; Zdeblick et al., 1994). The dense morphology of 
current resorbable polymer devices does not support the process of bone in-growth and thus must 
be used in conjunction with an osteoconductive scaffold material.  It is thus desireable to use the 
scCO2 process to develop constructs that can simultaneously support the biomechanical loads 
and provide a scaffold for bone growth.   
The hydrophilic character of the polymers plays a role in the biocompatibility of the 
constructs.  Water uptake experiments are a bulk method for comparing surface character of 
materials.  Specifically, osteoblasts have been shown to differentiate faster on hydrophilic 
surfaces, rather than hydrophobic ones (Baker et al, 2006; Bren et al., 2004). Generally, 
polymers that are lactic acid-based are very hydrophobic.  Addition of glycolic acid to these 
polymers increases the hydrophilic character of the constructs, as was evidenced by the increased 
water uptake (Figure 5).  Small variations in polymer chemistry, which impart a hydrophilic 
character to the constructs, may be possible without sacrificing the mechanical properties of the 
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construct.  These water uptake experiments are also frequently used clinically to assess the 
ability to load porous constructs with exogenous growth factors or autologous bone marrow 
aspirate.  Polymers (non-porous) currently in use in orthopaedic surgery are predominantly 
comprised of lactic acid, with small amounts of glycolic acid.  Further research should focus on 
examining the mechanical properties of resorbable polymer constructs with molar glycolic acid 
contents of less than 15%, as mechanical testing of 65:35PDLGA constructs demonstrated that 
polymer blends with higher glycolic acid contents have poor structural properties.  The scCO2 
processing method allows for a safe, versatile solvent that enables a wide range of pore 
architecture and the resultant properties. 
Potential limitations of this study include the use of SEM to measure pore 
interconnecitivty and pore structure.  Also, the overall level of porosity was not reported for the 
various constructs synthesized with different processing conditions.  Intrusion porisometric, or 
pyncnometric techniques are commonly employed in the quantification of pore structure, 
interconnectivty and degree of porosity.  While these properties were not reported, SEM was 
used to ensure that the pore structure and degree of porosity were similar between all samples 
that underwent mechanical testing and water uptake studies.   
The fact that the compression testing was performed in a non-physiological environment 
may be limitation. Hydrolytic breakdown of the biodegradable polymer has been shown to 
reduce static mechanical properties, as a function of time spent in an aqueous environment.  The 
objective of the current study was to quantify and compare the compressive mechanical 
properties at time zero, to engineer superior constructs based on pore size and processing 
parameters.  Experimentation is ongoing, which will seek to quantify the changes in both pore 
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structure and mechanical properties as a function of duration of exposure to a simulated 
physiologic environment. 
 
Conclusions 
Supercritical CO2 processing has been demonstrated to be a viable method to synthesize 
porous resorbable PDLGA constructs with varying glycolic acid compositions.  Further, the pore 
size range (236-239 m) and degree of pore interconnectivity of the constructs synthesized by 
scCO2 processing is similar to that found in iliac crest bone graft, which is considered to be the 
gold standard in spinal fusion procedures.   
The mechanical properties of 85:15PDLGA and 100PDLA samples indicate that these 
constructs may be suitable as bone graft substitutes for use in spinal fusion procedures.  Our 
study indicates that, through the use of scCO2 processing, it is possible to create resorbable 
constructs that possess the mechanical properties necessary to support biomechanical loads and 
architectures to facilitate bone in-growth.   
Incorporation of 35wt% glycolic acid improves the water uptake capacity of the 
constructs by altering the hydrophilic character of the polymer.  This increase in hydrophilicity 
may also enhance the bone in-growth capacity of the constructs by enhancing osteoblast 
response.   
In summary, scCO2 processing was found to be a promising method to develop porous, 
resorbable polymer constructs.  The mechanical properties, porous morphology and hydrophilic 
character of the resulting PDLGA constructs make them a potential candidate for bone grafting 
procedures in orthopaedic surgical procedures. 
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CHAPTER 5:  SUPERCRITICAL CARBON DIOXIDE PROCESSED RESORBABLE 
POLYMER NANOCOMPOSITES AS BONE GRAFT SUBSTITUTES 
Introduction 
Autogenous bone (autograft) remains a gold standard in numerous surgeries requiring 
bone grafting to achieve arthrodesis and fracture union.  The inherent osteoinductivity of 
autograft, coupled with its biomechanical strength make it a clear choice for the reconstruction or 
replacement of load bearing structures in the body.  Despite the success of surgical procedures 
utilizing autograft, complication rates as high as 30% have been associated with the harvest 
procedure (Malloy and Hillibrand, 2003; Samartzis et al., 2003; Wigfield and Nelson, 2001).  
These complications include harvest site necrosis, significant post-operative pain and fracture at 
the harvest site (Arribas-Garcia et al., 2009; Hu and Bohlman, 1994).  Allogenic bone (allograft) 
has been used in place of autograft with a high degree of success (Samartzis et al., 2003; 
Wigfield and Nelson, 2001).  Modern donor screening and sterilization methods have 
significantly reduced the rates of disease transmission, which until recently, was a significant 
risk in allogenic bone graft procedures (Mally and Hilibrand, 2002; Samartzis et al., 2003).  The 
mechanical properties as well as the osteoinductive capacity of allograft have been shown to be 
dependent on the type of sterilization employed (Malloy and Hilibrand, 2002; Chau and Mobbs, 
2009).  Additionally, allograft bone is in limited supply in some regions, which can limit its 
applicability in major surgical procedures, such as scoliosis correction (Chau and Mobbs, 2009; 
Moroni et al., 2009). 
Given the limitations of autograft and allograft bone, much attention has been given to 
the development of structural bone graft substitute materials.  Ceramic materials, such as calcium 
phosphates, have been investigated as bone graft substitutes for load bearing applications 
(Wigfield and Nelson, 2001).  While porous calcium phosphates such as corraline hydroxyapatite 
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have high compressive strengths, the brittle nature of the material can lead to progressive 
collapse of the graft resulting in poor bone healing (Chau and Mobbs, 2009).  Porous metallic 
constructs, such as Trabecular Metal™ (Tantalum, Zimmer Inc., WarsawIN) and Tritanium™ 
(commercially pure Titanium, Stryker Orthopaedics, MawahNJ) have also been introduced as 
structural bone graft substitutes.  The load bearing capacities of porous metal constructs are well 
documented in both static and dynamic conditions.  Unfortunately, long-term implantation of 
non-resorbing implants is associated with an omni-present risk of infection.  Further, the 
presence of a porous metallic construct may severely limit surgical options if a revision 
procedure is necessary.       
Due to such limitations there has been significant interest in developing resorbable 
polymers, such as poly-L-lactide (PLLA) and poly-L-glycolide (PLGA), for structural bone graft 
substitute applications (Chau and Mobbs, 2009; Moroni et al., 2009).  To impart a porous 
structure to PLLA and PLGA to enable bone growth, methods such as thermal/pressure induced 
phase separation, particulate leaching and gas foaming (Baker et al., 2009; Georgiou et al., 2007; 
Hu et al., 2002; Mathieu et al., 2005; Nam and Park, 1999).  Phase separation techniques often 
involve the use of volatile organic solvents which can be detrimental to cell growth (Nam and 
Park, 1999; Teng et al., 2007).  Particulate leaching must be used in combination with other 
methods, such as phase separation to yield a construct with connected porosity.  Gas foaming 
techniques, such as supercritical carbon dioxide (scCO2), avoid the use of harmful solvents and 
may not require additional methods to impart an interconnected porous structure (Baker et al., 
2009; Georgiou et al., 2007; Mathieu et al., 2005; Gualandi et al., 2010; Kanczler et al., 2010).   
The mechanical properties of porous resorbable constructs synthesized by the 
aforementioned means are not suitable for load bearing applications as the compressive modulus 
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and compressive strengths are much lower than that of native bone.  Failure of the constructs to 
withstand physiologic loading conditions may result in a reduced rate of healing and in some 
conditions may necessitate a revision surgical procedure. Researchers have examined reinforcing 
the polymer constructs with calcium phosphates (hydroxyapatite, -TCP), phosphate glass and 
carbon nanotubes (Georgiou et al., 2007; Mathieu et al., 2005; Kim et al., 2007; Khan et al., 
2008; Rezwan et al., 2006; Wang et al., 2008).  The addition of these materials to polymer 
matrices has resulted in modest gains in compressive strength and modulus. Calcium phosphates 
and phosphate glass particles have a tendency to agglomerate within polymer mixtures, which 
results in local heterogeneity that is detrimental to mechanical strength (Georgiou et al., 2007).  
There is therefore a need to develop a resorbable polymer nanocomposite system and a synthesis 
route which results in porous constructs with a relatively uniform dispersion of reinforcing 
particles.  
Recently, organically modified montmorillonite clays have been investigated as potential 
reinforcing agents in polymeric matrices (Horsch et al., 2006; Manitiu et al., 2008; Pavlidou and 
Papspyrides, 2008; Ray and Okamoto, 2003; Zeng et al., 2003).  The clay particles are composed 
of high aspect ratio silicate platelets which are approximately 100 – 500 nm in length and 1 nm 
thick. These platelets are held together in stacks by van der Waals forces and the equilibrium 
platelet spacing of 1 nm is generally modified by chemical techniques. One common method of 
increasing platelet spacing is modification of the clay surface with alkylammonium salts.  
Increasing the spacing or the dispersion of the clay platelets increases the potential for intimate 
contact between polymer chains and numerous clay platelets, thus reducing polymer chain 
mobility and improving mechanical properties (Horsch et al. 2006; Manitiu et al., 2008; Pavlidou 
and Papspyrides, 2008; Ray and Okamoto, 2003).  The processing method used to create clay-
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polymer nanocomposites also plays a role in the resulting mechanical behavior.  Melt processing, 
high shear mixing and post-processing heat treatments have been employed to enhance polymer 
chain-clay platelet contact, with moderate property improvements (Pavlidou and Papspyrides, 
2008; Ray and Okamoto, 2003).  On the other hand, scCO2 processing appears to be a very 
effective way to improve mechanical properties of polymer-clay nanocomposites (Horsch et al., 
2006; Manitiu et al., 2008; Zeng et al., 2003) for film and molded part applications.  Diffusion of 
CO2 within the clay particles and rapid depressurization leads to an increase in platelet spacing, 
as well as polymer chain contact (Horsch et al., 2006; Manitiu et al., 2008). The use of scCO2 
processing for dispersed biodegradable poly-d-lactide (PDLA) nanocomposites is a new concept 
explored in this study.  
Supercritical CO2 processing has been previously used to disperse nanoclays in 
resorbable polymer matrices and to synthesize porous resorbable polymer scaffolds (Baker et al., 
2009; Zeng et al., 2003).  Using scCO2 processing to synthesize nanoclay-resorbable polymer 
nanocomposites may result in the production of porous scaffolds, which are suitable for 
structural bone graft substitute applications.  The purpose of this study is to examine the 
structure, mechanical properties and biocompatibility of porous resorbable PDLA polymer 
nanocomposites synthesized by supercritical carbon-dioxide processing.   
 
Materials and methods 
Materials- 
Constructs were prepared from 100% poly(D-lactic acid) (100PDLA, Lakeshore 
Biomaterials, Birmingham, AL).  Nanocomposites were formed by adding nano-structured 
Montmorillonite clay platelets (nano-clays).  Organic modifiers based on ammonium salts are 
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used to increase the intergallery spacing between silicate platelets, thus facilitating dispersion.  
The nano-clay used in this study was organically modified with a methyl dehydrogenated tallow 
(Cloisite 93A, Southern Clay Products, Austin, TX), as shown in Figure 1, and was used “as-
received” from the manufacturer.  The size distribution of the dry particles of Cloisite 93A, 
according to the manufacturer are as follows: 90% of particles are less than 13 m, 50% less 
than 6 m and 10% less than 2 m.  
 
Figure 1.  Illustration of the chemical structure of the organic modifier used to increase basal 
platelet spacing in Cloisite 93A nanoclay. 
 
Construct Synthesis  
Pure polymer constructs were prepared according the previously described methods 
(Baker et al., 2009).  Briefly, polymers were ground to an average particle size of 250-500 m 
and placed in a steel tube (28 mm O.D. x 61 mm H).  The tube restricts radial expansion of the 
polymer, but allows for expansion in the vertical direction.  The polymer-filled tube, each with 
2.0 g of ground polymer, were placed into a supercritical fluid reactor and saturated with CO2.  
The internal pressure was elevated to 13.8 Mpa at an internal temperature of 35
o
C to induce a 
supercritical phase transformation in the CO2.  After 60 minutes of soaking, the reactor was 
rapidly depressurized at a rate of 0.3-0.4 Mpa/s.   
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Synthesis of clay-polymer nanocomposite constructs was performed similarly.  Nanoclay 
particles were mechanically mixed with 2.0 g of ground polymer with total clay loading of 
1wt%, or 2.5wt%.  The steel tubes were placed into the supercritical fluid reactor and saturated 
with CO2.  Processing nanocomposite constructs at 35
o
C (similar to pure constructs), resulted in 
pore sizes much smaller than those found in the pure constructs.  As such, a higher temperature 
was utilized for nanocomposite processing, so that both constructs would have similar pore sizes.  
The internal pressure of the reactor was elevated to 13.8 Mpa and the temperature was raised to 
100
o
C.  After 60 minutes of soaking in the supercritical CO2, the reactor was rapidly 
depressurized at a rate of 0.3-0.4 Mpa/s.  The process was repeated to yield samples of 
100PDLA with 1wt% Cloisite 93A (100PDLA-93A-1) and 2.5 wt% 93A (100PDLA-93A-2.5).   
Constructs were freeze-fractured with liquid nitrogen in the vertical (direction of CO2 
escape) and transverse (direction perpendicular to CO2 escape) directions.  Fracture surfaces 
were coated with a thin film of AuPd and subjected to scanning electron microscopy (SEM, 
JEOL JSM 6400, JEOL Ltd.).  SEM was performed at a working distance of 15 mm and an 
accelerating voltage of 20 kV.  Measurements of pore size, pore wall thickness and qualitative 
assessments of pore interconnectivity were performed using digital image analysis software 
(Revolution, 4Pi Analysis).  Measurements were conducted on a minimum of three vertical and 
three transverse fracture surfaces.  At least eight images were analyzed from each fracture 
surface.  Pore dimensions were measured for 20 pores per fracture surface image.   
 
Characterization of Nanoclay Dispersion  
A RigakuSmartLabDiffractometer with a Cu Kα X-ray source (λ = 1.54 Å) and an 
accelerating voltage of 40 kV at a current of 40 mA was used to determine the intergallery 
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spacing of the clay/polymer nanocomposites. Samples were placed in a custom made, zero-
background quartz sample holder that is 0.9 mm in depth and diffraction scans were collected 
from 0.1 to 10º 2 at a scan rate of 3.0 degrees/min at a step size of 0.3 degrees. Several scans 
were obtained from different locations in the sample and verified to be reproducible when 
diffraction patterns were superimposed on one another. The 2θ angle was determined using the 
JADE software that accompanies the diffractometer and the d001 spacing for the clays was 
calculated using Braggs’ Law of diffraction. The intergallery spacing was then found by 
subtracting 1 nm (platelet thickness) from the d001 spacing. 
 
Rheology  
A Rheometric Scientific RSA II rheometer (shear sandwich geometry 15.98 mm x 12.7 
mm x 0.55 mm) was used to perform melt rheological measurements under oscillatory shear. 
Rectangular slabs of samples were prepared by melt pressing the foam constructs into a mold at 
80ºC between Teflon plates followed by annealing under vacuum at 80ºC to remove any residual 
carbon dioxide, and also to remove the porous structure. The materials were loaded and allowed 
to equilibrate for 1 hour at the desired temperature. Rheological measurements were performed 
at 80ºC and 120ºC for all samples, and time-temperature superposed Data at both these 
temperatures are shown with a reference temperature of 80ºC. Strain sweeps were performed to 
ensure that the dynamic moduli were linear in the strain range used and the linear viscoelastic 
measurements were made at low strains (γo< 0.05) to minimize microstructure destruction. The 
frequency range used was 0.01 = ω = 100 rad/s and the property of time-temperature 
superposition was used to create master curves with a reference temperature of 80ºC. 
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Mechanical Testing  
Cylindrical cores (n = 6 per testing group) with a diameter of 10 mm were obtained from 
the porous PDLA constructs by using an osteochondral biopsy system.  Coring the constructs 
was necessary to ensure that the dense outer skin was not present during mechanical testing.  The 
cores were sectioned to a height of 10 mm and trimmed with a scalpel to ensure that the ends 
were parallel.  The samples were placed between smooth stainless steel platens in a 
servohydraulic materials testing machine (850 Mini-Bionix, MTS Inc., Eden Prairie, MN).  
Constructs were loaded in compression under displacement control at a rate of 0.5 mm/min until 
a strain of 50% was reached.   
The compressive strength of the constructs was defined as the maximum load divided by 
the initial cross sectional area.  Compressive modulus was determined by calculating the slope of 
the linear region of the load-displacement curve.  A one-way analysis of variance with a 
Bonferroni correction and an  of 95% was used to determine the statistical significance of 
mechanical data as a function of construct composition. 
 
Osteoblast Response to Porous Nanocomposite Constructs 
Human osteoblast cells (HOB, PromoCell, Heidelberg, Germany) were cultured in α-
modified minimum essential medium (α-MEM, Gibco, USA; containing 2.0 mM L-glutamine 
and 1 mM sodium pyruvate, without phenol red) supplemented with Osteoblast Growth Medium 
SupplementMix (PromoCell; containing 10% FBS) and 1% penicillin/streptomycin (Gibco).  
Cell cultures were maintained in 5% CO2 with 95% air at 37ºC until 85% confluence.  Cells were 
lifted using 0.05% trypsin/0.5 mM EDTA solution (PromoCell), concentrated, resuspended in 
growth medium, and counted using a hemocytometer. 
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Cells were seeded directly onto 10 mm diameter porous cores of 100PDLA, 100PDLA-1 
and 100PDLA-2.5 nanocomposite constructs at a density of 4x10
4 
cells per construct,with a 
sample size of six per treatment group.  Controls were performed using the same cell density on 
polystyrene culture plates (n=6). Cultures were maintained for seven days and medium collected 
and replaced every 24 hours. 
Alkaline phosphatase activity was determined from cell culture supernates every 48 hours 
by immunoenzymatic assay (QuantiChrom ALP Assay Kit, BioAssay Systems, Hayward, CA).  
The expression of osteoprotegerin was also quantified in cell culture supernates using a bead-
based immunoassay (Human Bone Panel 1B, Millipore, Billerica, MA)  at the same time points.  
All samples were analyzed in duplicate for a total sample size of 12 per treatment group per time 
point. A one way analysis of variance (ANOVA) with Bonferroni correction was used to 
compare the expression of alkaline phosphatase and osteoprotegerin by cells cultured on 
polystyrene culture plates, 100PDLA, 100PDLA-1wt% and 100PDLA-2.5wt% constructs at each 
time point.   
Seeded nanocomposite constructs were also subjected to SEM to examine cell 
morphology and mineralization.  Constructs were fixed in gluteraldehyde for 24 hours and then 
subjected to critical point drying.  After drying, the samples were sputter-coated with AuPd and 
visualized with SEM at a working distance of 8 mm and an accelerating voltage of 20 kV.  
Energy dispersive X-ray spectroscopy (EDX, Link Analytical) was used to characterize the 
composition of regions of suspected mineralization. 
 
In Vitro Osteoclast Response to Nanoclay 
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To investigate the degree to which bare nanoclay would stimulate an osteolytic response 
in vivo, rat monocytes from bone marrow (Rat Osteoclast Precursor Cells, Kamiya Biomedical) 
were cultured on disks of human dentine.  Culture media consisted of alpha-minimum essential 
media (-MEM) supplemented with macrophage-colony stimulating factor (M-CSF, 50 ng/mL) 
and receptor activator of nuclear kappa- ligand (RANKL, 50 ng/mL). M-CSF and RANKL are 
potent differentiators of macrophages and monocytes to a committed osteoclastic lineage.Cloisite 
93A and Cloisite 30B nanoclays were suspended in 95% ethanol and sonicated for 15 minutes.  
Cloisite 30B is another organically-modified nanoclay, and possesses a similar particle size 
distribution as Cloisite 93A.  Cloisite 30B is modified with methyl tallow bis-2-hydroxyethyl 
quaternary ammonium, rather than methyl dehydrogenated tallow ammonium like Cloisite 93A.  
Nanoclays were then dried, lyophilized and suspended in phosphate buffered saline (PBS) at a 
concentration of 5.0 mg/mL.  100L of each nanoclay suspension was added to the cultured 
osteoclasts, 48 hours after differentiation.  100L of sterile PBS without particles was used as a 
control. 
Pit formation on the dentine discs and the expression of tartrate resistant acid phosphatase 
(TRAP) were used as measures of osteoclast activity.  To assess pit formation, cells were lysed 
from the substrate with a 2% trypsin solution.  Dentine disks were stained with Mayer’s 
hematoxylin to provide depth dependent contrast changes under phase contrast microscopy.  
Disks were imaged by phase contrast microscopy (Olympus IX-71, Olympus Inc.) equipped with 
digital image acquisition.  Pit formation was qualitatively compared between nanoclay-treated 
groups and the control group after seven, 14 and 21 days in culture.  TRAP staining of the 
dentine disc was performed at each timepoint by first washing the dentine in PBS to remove 
bound culture medium and then fixing the samples in 10% buffered formalin.  The discs were 
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then incubated with a solution of tartrate-containing buffer and a chromogenic substrate at 37
o
C 
for 60 minutes.  Following a wash in PBS, the discs were imaged with light microscopy. 
 
Results 
Structure and Morphology 
Scaffold preparation using the supercritical CO2 method resulted in pure 100PDLA 
polymer constructs with mean pore diameters of 236 m (±5 m).  Similar pore diameters were 
noted for PDLA-clay nanocomposite constructs (both at 1 and 2.5 wt% clay loading), as 
illustrated in Figure 2, and shown in Table 1.  SEM analysis of multiple fractured surfaces 
showed that the pore sizes were uniform (relatively low standard deviation). No differences in 
pore interconnectivity were observed as assessed by analysis of fracture surfaces by SEM.  
 
 
Figure 2.  Scanning electron micrographs of the porous structure of 100PDLA (left) and 
100PDLA-2.5wt% (right). 
 
Scaffolds displayed a dense skin on the outside of the constructs.  This layer abruptly 
transitioned to a porous interior.  The morphology of the constructs was thus similar to that of 
iliac crest bone grafts commonly used in spine surgery, as shown in Figure 3.  The addition of 
nanoclay had no observable effect on the morphology or thickness of the dense shell.   
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Figure 3.  Scanning electron micrographs of human corticocancellous bone harvested from the 
iliac crest (left) and a 100PDLA-2.5wt% nanocomposite construct demonstrating a resemblance 
of both cortical and cancellous bone structure.   
 
Small Angle X-ray Diffraction 
Diffraction spectra of the nanocomposites showed a shift in the d001 peak of pure Cloisite 
93A from 3.36
o
 to 4.41
o
 2, as shown in Figure 4.  Using the Bragg equation it was determined 
that this magnitude of shift in the 2 position corresponds to an increase in clay platelet spacing 
of 1.79 nm (from 1.62 nm to 3.41 nm) after scCO2 processing.  Increased platelet spacing, as 
determined by X-ray diffraction has been used to determine the degree of intercalation of 
organically modified clays in polymer matrices and the extent of polymer – clay interactions 
present in the system (Horsch et al., 2006; Manitiu et al., 2008; Pavilidou and Papspyrides, 2008; 
Ray and Okamoto, 2003).  The large clay inner- gallery spacing in the nanocomposite indicates 
that a large degree of dispersion and that strong interactions are present between the polymer and 
the clay organic modifier. Also, the weak and broad d001 spacing in the 100PDLA/2.5wt% 93A 
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sample compared to the “as received” Cloisite 93A is due to the low clay loading and a wide 
distribution of clay inner-gallery spacing.  
 
 
Figure 4.  Small angle X-ray diffraction spectra of pure Cloisite 93A nanoclay and 100PDLA-
2.5wt% demonstrating a significant increase in d-spacing of the clay. 
 
Rheology 
Oscillatory shear rheology was performed on reactangular slabs of scCO2-processed 
constructs after being melt pressed into a mold at 80ºC to remove all bubbles (no pores). This is 
to assess the degree of clay dispersion and the extent of polymer-clay interactions (Horsch et al., 
2006; Manitiu et al., 2008; Pavilidou and Papspyrides, 2008; Ray and Okamoto, 2003). In melt 
rheological studies the storage (G’) and the loss (G’’) moduli are plotted as a function of 
oscillatory shear frequency, as shown in Figure 5. The frequency at which they cross (crossover 
frequency) is characteristic of the matrix polymer relaxation time. Upon addition of clay, to the 
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PDLA matrix, a shift in the G’/G” crossover frequency, from 0.23 to 0.10 rad/s was observed. 
More importantly, an increase in the storage and loss moduli was seen upon addition of 2.5% 
clay.  Such observations can be attributed to a significant decrease in mobility of polymer chains 
due to extensive interaction with the dispersed nano-clay (Horsch et al., 2006; Manitiu et al., 
2008; Pavilidou and Papspyrides, 2008; Ray and Okamoto, 2003), which typically improves the 
mechanical properties.  
 
Figure 5.  Time-temperature superposed graphs of storage (G’) and loss (G’’) moduli of 
100PDLA and 100PDLA-2.5wt%.   
 
Mechanical Testing of Constructs 
Pure PDLA constructs exhibited a compressive strength of 3.41 Mpa (±0.54 Mpa) and a 
compressive modulus of 33.79 Mpa (±9.30 Mpa).  The addition of 1wt% Cloisite 93a nano-clay 
to the 100PDLA increased the compressive strength to 6.10 Mpa (±0.83 Mpa) and compressive 
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modulus to 45.92 Mpa (±15.33 Mpa), as shown in Figure 6.  Nanocomposite constructs 
containing 2.5wt% nano-clay showed an average compressive strength of 7.15 Mpa (±2.02 Mpa) 
and average compressive modulus of 68.42 Mpa (±32.41 Mpa).  Statistical analysis showed that 
the increase in compressive strength upon addition of 1wt% of nanoclay was significant (p = 
0.008) when compared to pure samples, while the change in modulus was not significant 
(p=1.000).  The increase in compressive strength upon addition of 2.5wt% nanoclay was 
significant when compared to pure samples (p<0.001), as was the change in modulus (p=0.040).  
The increase in compressive strength from 1wt% to 2.5wt% nanoclay was not significant 
(p=0.545), nor was the increase in compressive modulus (p=0.265).  A post-hoc power analysis 
revealed the statistical power to be 98.9% for the comparison of compressive strengths, and 
49.6% for the compressive moduli. 
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Figure 6.Compressive strength and compressive modulus of porous cores of 100PDLA, 
100PDLA-1wt% and 100PDLA-2.5wt%. 
 
Biocompatibility of Constructs- 
Alkaline phosphatase activity and expression of osteoprotegerin by human osteoblasts 
cultured on the porous constructs was quantified by ELISA at days 1, 3, 5 and 7.  On Day 1, 
alkaline phosphatase activity was similar between controls (polystyrene culture plates) and 
constructs (p=0.093), as shown in Figure 7. Expression of osteoprotegerin was higher for control 
wells when compared with 100PDLA-2.5wt% constructs (p=0.007).  At Day 3, 100PDLA 
constructs had the highest alkaline phosphatase activity, but the only statistically significant 
difference was between 100PDLA and 100PDLA-2.5wt% constructs (p=0.013).  Osteoprotegerin 
expression was also highest for 100PDLA constructs at Day 3 with significant differences 
between control wells, 100PDLA-1wt% and 100PDLA-2.5wt% constructs (p<0.001, p<0.001 
and p<0.001, respectively).  On Day 5, both control wells and 100PDLA-1wt% constructs 
showed higher alkaline phosphatase activity (p=0.006 and p=0.035, respectively).  100PDLA 
constructs again showed the highest expression of osteoprotegerin with significant differences 
between control wells, 100PDLA-1wt% and 100PDLA-2.5wt% constructs (p=0.001, p=0.004 
and p<0.001, respectively).  By Day 7, the differences in alkaline phosphatase activity and 
osteoprotegerin expression were again not significant (p=0.162 and p=0.135, respectively).    
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Figure 7.Alkaline phosphatase activity (left) and osteoprotegerin expression (right) of human 
osteoblasts cultured on 100PDLA, 100PDLA-1wt% and 100PDLA-2.5wt% compared against 
polystyrene controls. 
 
 
Examination of the nanocomposite scaffolds after culturing cells for 21 days revealed 
copious amounts of extracellular matrix deposition (Figure 8).  The deposits were comprised 
mainly of calcium and phosphorus as determined by EDX.  This composition is indicative of the 
mineralization process.  Cells and calcium phosphate deposits could be seen within pores deep in 
the porous network of the constructs.  The presence of cells and deposits in the center of the 
constructs indicates that cells are able to infiltrate the open porous structure of the 
nanocomposite constructs.  Some surface degradation was noted on the outermost pore walls on 
both nanocomposite formulations.  This degradation manifested as irregularly shaped pores and 
erosive scalloping.  There were no qualitative differences noted in the degradation behavior of 
the pure PDLA and PDLA-clay constructs.  
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Figure 8.  Scanning electron micrographs of 100PDLA-2.5wt% 93A constructs after 28 days in 
culture with human osteoblasts.  The top two images show a fibrous extracellular matrix 
deposited by the osteoblasts, which is rich in calcium and phosphorus.  The bottom image 
displays some degradation of the polymer as a function of exposure to the culture media. 
 
 
Nanoclay-Treated Osteoclast Pit Formation and TRAP Expression 
 
Pit formation by osteoclasts was qualitatively assessed with phase contrast microscopy, 
as shown in Figure 9.  Discs from osteoclasts exposed to saline should no pit formation at seven 
days.  Very little pit formation was noted at the seven day timepoint on discs from osteoclasts 
exposed to Cloisite 93A.  Pit formation was very evident on discs from osteoclasts treated with 
Cloisite 30B at day seven.  Pits increased in both size and number on discs from osteoclasts 
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treated with Cloisite 30B.  A slight increase in the number of pits was noted for Cloisite 93A 
treated osteoclasts at the 14 day timepoint.  At the 21 day timepoint, pit formation was visible on 
all substrates.   
 
Figure 9.  Dentine discs stained with Mayer’s hematoxylin to reveal pit formation by osteoclasts 
exposed to PBS (top left), Cloisite 93A in PBS (top right) and Cloisite 30B (bottom). 
 
TRAP staining intensity, which is correlated with resorptive activity within osteoclasts, 
was assessed by light microscopy.  No significant difference in the red-brown TRAP staining 
was found between osteoclasts treated with saline and those treated with Cloisite 93A at any time 
point.  However, Cloisite 30B-treated osteoclasts elicited the most intense expression of TRAP at 
each time point, as shown in Figure 10. 
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Figure 10.  TRAP staining of osteoclasts on dentine disks exposed to PBS (top left), Cloisite 93A 
in PBS (top right) and Cloisite 30B in PBS (bottom).   
 
 
Discussion 
The porous morphology of the resorbable PDLA nanocomposites indicates suitability for 
use as a scaffold for bone growth.  Pore sizes in the range of 100-300 m have been shown to be 
sufficient to support neovascularization, and cellular infiltration (Moroni et al., 2009; Khan et al., 
2008).  Both pure and nanocomposite constructs synthesized for this study exhibited average 
pore diameters of 236.2 m, 243.1m and 239.8 m for 100PDLA, 100PDLA-1 and 100PDLA-
2.5 constructs, respectively.  Pore interconnectivity is also essential for the in vivo viability of 
scaffolds, as it ensures the ability to transport nutrients to the center of the constructs.  Though 
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no quantitative techniques were employed in this study, SEM of fracture surfaces showed that 
both pure and nanocomposite scaffolds had a high degree of interconnectivity.  Overall, no 
significant effect of nano-clay addition was seen on the resulting morphology of the 
nanocomposite constructs. Both pure and nanocomposite constructs demonstrated a dense shell, 
which transitioned abruptly to a porous interior.  The addition of clay had no observable effect 
on the thickness or morphology of the shell, or its transition to a porous interior.  This 
morphology is similar to that of the cortico-cancellous bone grafts commonly employed in 
orthopaedic surgery (Malloyo and Hilibrand, 2002; Samartzis et al., 2003; Wigfield and Nelson, 
2001).  In these grafts, the dense cortical shell provides rigid support during biomechanical 
loading.  Due to the similarity in structure, it is hypothesized that the dense shell of the 
nanocomposite scaffolds would play a similar role.  This hypothesis was not tested in this study, 
as all mechanical testing was performed on porous cores taken from the interior of the constructs.   
Small angle X-ray diffraction showed a significant increase in the 2 position of the 
[001] plane of incorporated nano-clay.  The shift of the peak to a lower 2 position is indicative 
of an increase in the spacing of clay platelets (Horsch et al., 2006; Manitiu et al., 2008; Pavilidou 
and Papspyrides, 2008; Ray and Okamoto, 2003).  The basal spacing of the pure nano-clay used 
in this study was found to be 2.62 nm.  After scCO2 processing the clay-polymer mixtures, the 
spacing increased to 4.40 nm.  The measured increase in spacing is due to polymer chain 
infiltration between the clay layers (Horsch et al., 2006; Manitiu et al., 2008).  During 
processing, CO2 is able to diffuse in between the clay platelets as well as increase the mobility of 
the polymer, which is solvated by the CO2.  This facilitates polymer chain infiltration between 
clay platelets and further increases platelet spacing.  Upon rapid depressurization, the expansion 
of CO2 within the particles forces a fraction of the clay platelets apart, significantly increasing 
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the surface area available for polymer interaction.  This increase in dispersion as well as the 
intercalation of polymer between clay platelets results in reinforcement of the polymer matrix 
and reduced mobility of the polymer chains, and can be a key factor in mechanical property 
improvements (Horsch et al., 2006; Manitiu et al., 2008; Pavilidou and Papspyrides, 2008; Ray 
and Okamoto, 2003). 
Rheology is a commonly used tool in nanocomposite characterization for investigating 
polymer-particle interaction effects, as well as particle dispersion effects. Characterization of the 
rheological behavior of the pure PDLA and PDLA-clay nanocomposite constructs showed that 
the nano-clay reduced the mobility of polymer chains within the construct.  A shift in the 
frequency at which the storage (G’) and loss (G”) moduli cross indicates a change in the so-
called “characteristic relaxation time” of the polymer.  In this case, a reduction in the crossover 
frequency from 0.23 rad/s to 0.10 rad/s is indicative of over a doubling of the relaxation time of 
the polymer.  Additionally, the low frequency “terminal” region of the storage modulus has a 
reduced slope when compared to the pure polymer which indicates that there is a significant 
amount of clay dispersion, and improved polymer-clay interactions in the processed construct 
(Ray and Okamoto, 2003). Such strong polymer clay interactions and dispersion are necessary 
for the efficient transfer of stress from the matrix to the filler that is necessary to enhance 
mechanic properties. 
Mechanical testing of the porous constructs showed significant improvements in 
compressive strength with the addition of as little as 1wt% nano-clay.  Nanocomposites with 2.5 
wt% nano-clay showed the highest compressive strength and compression modulus.  Results 
from mechanical testing show that the nanocomposite constructs compare favorably to 
cancellous and cortico-cancellous human bone.  Compressive strengths of the nanocomposites 
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reported in this study exceed the ranges of human cancellous bone from the mandible and lumbar 
vertebral bodies as reported in literature (Giesen et al., 2001; Jensen et al., 1990; Mosekilde and 
Mosekilde, 1986; Yeni and Fyhrie, 2001).  Mosekilde, et al. measured the whole vertebral body 
ultimate compressive strength to range from 1.5 to 7.8 Mpa (Mosekilde and Mosekilde, 1986).  
The compressive strengths of thenanocomposites at 50% strain are within the range of the 
ultimate compressive strength of human lumbar vertebral bodies (approximately 2.0 – 8.0 Mpa) 
reported by Ebbesen, et al (Ebbesen et al., 1999).  Mechanical testing data presented in this study 
are for porous cores taken from the pure and nanocomposite constructs.  It is hypothesized that 
the dense shell that is present on the outside of the constructs will increase the resistance to 
mechanical loading, thereby improving its suitability for load-bearing applications.   
The mechanical properties of the nanocomposite scaffolds also compare favorably to 
those reported for other synthetic polymer nanocomposite constructs (Georgiou et al., 2007; 
Mathieu et al., 2005; Gualandi et al., 2010; Teng et al., 2007; Khan et al., 2008; Rezwan et al., 
2006).  In a recent review article by Rezwan, et al., the reported compressive strengths for 
PLGA, PLLA and PDLLA matrices filled with calcium phosphates, Bioglass or phosphate glass 
fabricated using a variety of techniques range from 0.07 to 0.42 Mpa (Rezwan et al., 2006).  
Mathieu, et al. have reported that utilizing a similar supercritical CO2 process a compressive 
strength of up to 6.0 Mpa was achieved in PLA-TCP and PLA-HA composites (Mathieu et al., 
2005).   The improvements in compressive strength and modulus observed in the polymer-clay 
nanocomposites is likely due to the high reinforcement capacity of the nano-clays.  The nano-
clay platelets that are dispersed in the polymer matrix during scCO2 processing have a very large 
aspect ratio, allowing for greater polymer-clay contact and restriction of polymer chain mobility.  
The degree with which these nano-clays can be dispersed in the polymer matrix also improves 
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mechanical properties, when compared to polymer constructs reinforced with calcium 
phosphates.  Agglomeration of calcium phosphate particles within polymer matrices has been 
cited as a potential reason for the relatively modest improvements in strength (Georgiou et al., 
2007; Mathieu et al., 2005).  The use of organic modifiers improves the ability of nano-clays to 
be dispersed in polymer matrices (Horsch et al., 2006; Manitiu et al., 2008; Pavilidou and 
Papspyrides, 2008; Ray and Okamoto, 2003).  Rapid depressurization and polymer chain 
infiltration during scCO2 processing also facilitates improved dispersion of the nano-clays, 
leading to improvements in mechanical behavior(Horsch et al., 2006; Manitiu et al., 2008).   
Preliminary investigations of biocompatibility of the supercritical CO2-processed 
resorbable polymer nanocomposite constructs suggest an overall neutral, or bioinert response by 
human osteoblasts.  While alkaline phosphatase activity and osteoprotegerin expression was 
higher for control and 100PDLA constructs at certain time points, these differences were 
insignificant after seven days in culture.  Aluminosilicate materials, similar in composition and 
structure to the nano-clays used in this study, have been shown to positively influence osteoblast 
proliferation, differentiation and mineralization (Haroun et al., 2009; Katti et al., 2008).  
However, this is the first study to examine human osteoblast response to nano-clay which is 
highly dispersed in a resorbable polymer matrix by scCO2.  The nano-clays used in this study are 
organically-modified with alkyl-ammonium salts.  However, these moieties are not likely to be 
exposed to the cellular environment, as they are dispersed in the polymer matrix..  The relatively 
low weight-percent of clay used in this study also minimizes the chance of organic modifier-
induced cytotoxicity.  No toxic, or apoptotic response was noted within the cultures, as 
evidenced by the maintenance of cell attachment and osteoblastic cell morphology.       
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Ostoeblast extracellular matrix deposition on the nanocomposite constructs also indicates 
favorable biological interaction.  Calcium phosphate-rich deposits could clearly be seen on the 
surface of the constructs, as well as within pores.  This deposition was observed to also occur at 
the very center of the cultured constructs, which indicates that osteoblasts are able to penetrate 
the porous network of the nanocomposite constructs.  Cellular infiltration of these constructs is 
important for their in vivo use as bone graft substitutes.  The diameter of the pores also suggests 
that these constructs would also support neovascularization, which is integral for nutrient 
transport.  Further, the dense to porous morphology imparted by the scCO2 process closely 
resembles the structure of cortico-cancellous bone grafts currently used in orthopaedic surgery.  
This morphology has been shown to be important both in terms of new bone growth, as well as 
in the support of biomechanical loads in vivo.   
Osteoclast pit formation and TRAP expression showed a dependence on the type of 
nanoclay modifier used.  Exposure of cultured osteoclasts to Cloisite 30B resulted in consistently 
higher concentrations of resorption pits at all time points, compared to Cloisite 93A and control 
wells.  Cloisite 93A also elicited the greatest expression of TRAP by the cultured osteoclasts.  
Since the particle sizes of Cloisite 93A and Cloisite 30B are similar, as are their base 
compositions (both Montmorillonite clays), it can be deduced that the difference in organic 
modifier led to the differences observed in resorption pit formation and TRAP expression by the 
osteoclasts.  While differences in biologic response relative to differences in nanoclay modifier 
have not been described, both Rueda and Styan have detailed the effects of Cloisite 30B clays on 
cell viability and proliferation.  Both in vitro studies showed a dose-dependent reduction of cell 
viability and proliferation upon exposure to Cloisite 30B.  While no assays were performed in 
the current study to quantify viability and proliferation, the confluence of osteoclasts seemed 
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similar between treatment groups and time points.  Styan et al., characterized the release of 
quaternary ammonium compounds (QACs) in vitro during their fibroblast study.  Both Cloisite 
93A and 30B contain QACs in the employed modifier.  It is hypothesized that the modifier for 
Cloisite 30B is either less strongly bound to the nanoclay resulting in higher in vitro 
concentrations of QACs, or that the specific QAC used for Cloisite 30B is more inflammatory. 
 
Conclusions 
Supercritical CO2 processing of resorbable polymer/nano-clay mixtures results in the 
formation of porous nanocomposite constructs, which exhibit biocompatibility and significant 
improvements in mechanical properties.  Porous resorbable polymer/nano-clay nanocomposite 
constructs prepared using scCO2 processing exhibit improvements mechanical properties 
comparable to human cancellous and cortico-cancellous bone (2.5 fold increase in compressive 
strength compared to pure polymer constructs).  Improvements in mechanical properties of the 
constructs are related to the dispersion of nanoclay within the polymer matrix and subsequent 
reduction in polymer chain mobility.  The biocompatibility of the constructs, as determined by 
alkaline phosphatase activity and expression of osteoprotegerin by cultured human osteoblasts, 
was similar to polystyrene culture plate controls and resorbable polymer constructs without clay 
after seven days in culture.  Further in vivo studies are necessary to determine the full extent of 
cellular response to polymer-clay nanocomposites, as well as construct degradation kinetics.  
Supercritical CO2-processed resorbable polymer nanocomposites represent a potential alternative 
to autograft and allograft in orthopaedic procedures requiring bone graft.     
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CHAPTER 6:  INFLUENCE OF POLYMER END FUNCTIONALITY AND NANOCLAY 
ORGANIC MODIFICATION ON DISPERSION AND RHEOLOGY 
Introduction 
 Nanocomposites composed of organically-modified Montmorillonite clay dispersed in 
polymer matrices have garnered significant attention relative to significant improvements in 
physical properties.  Depending on the composite system, the addition of organically-modified 
clay (nanoclay) can reduce gas permeability, increase flame resistance, improve thermal stability 
and enhance both static and dynamic mechanical properties.  As such, the applications for 
polymer-nanoclay composites are as varied as the methods for synthesizing them.  Owing to the 
significant improvements in mechanical properties even at low concentrations of nanoclay, 
polymer-clay nanocomposites have been investigated.   
 Recently, our group has employed supercritical carbon dioxide (scCO2) processing to 
create porous resorbable polymer nanocomposites.  These nanocomposites are composed of 
organically modified Montmorillonite clay dispersed in a matrix of poly-D-lactide (PDLA).  
Processing with scCO2 simultaneously disperses nanoclay throughout the matrix and induces an 
interconnected porous morphology to the construct.  Static mechanical properties of the resulting 
construct constitute a two-fold change in ultimate compressive strength and significant 
improvements in compressive modulus.  Rheological measurements of heat-pressed, dense 
PDLA-clay nanocomposites illustrate a significant shift in the frequency of storage and loss 
moduli cross-over, indicative of a large decrease in the characteristic relaxation time of the 
polymer matrix.  An increased slope in the terminal region of the nanocomposite, compared to 
pure polymer also indicated favorable polymer clay interactions.  Both of these characteristics 
point towards the restriction of polymer chain mobility as the dominant mode of reinforcement 
by the organically-modified Montrmorillonite clay in the PDLA matrix.   
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 It is recognized that enhancing the level of favorable polymer-clay interaction will result 
in an overall enhancement of mechanical properties of the nanocomposite.  One potential method 
of enhancing polymer-clay interaction is to alter the end functionality of the polymer.  Chen et al, 
examined the influence of functionalizing Montmorillonite clay that had already been 
organically modified with epoxy groups on dispersion within a poly-L-lactide matrix.  The 
addition of the epoxy end groups to the organically-modified clay led to an increase in tensile 
strength, elastic modulus and elongation at failure when comparied to PLLA-clay 
nanocomposites without epoxy-functionalized clay.  Epoxy functionality of the nanoclay 
enhanced the degree of positive interaction with PLLA polymer chains during melt compounding 
(Chen et al., 2005).   
The purpose of this study is to examine the influence of polymer end functionality and 
nanoclay organic modification regime on dispersion and melt-rheology of PDLA-clay 
nanocomposites processed by scCO2.  Interactions.  Poly-D-lactide with either a lauryl ester, or 
carboxylic acid end functionality were scCO2 processed with Cloisite 93A or Cloisite 30B.  
Resulting constructs were characterized with small angle X-ray diffraction (SAXD) and melt-
rheology to determine the extent of clay dispersion within the polymer matrix, as well as the 
improvements in dynamic mechanical properties.   
Materials and Methods 
Materials 
Nanoclays used in this study remained in the as-received state from the manufacturer 
(Southern Clay Products Inc., Houston, TX).  Cloisite 93A, which is a Montmorillonite clay 
organically modified with methyl dihydroginated tallow ammonium slat (modifier concentration 
= 95 meq/100 g clay) and Cloisite 30B, which is a Montmorillonite clay organically modified 
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with methyl, tallow, bis-2-hydroxyethyl quaternary ammonium salt (modifier concentration = 90 
meq/100 g clay) were used to create nanocomposites.  The size distribution of dry particulate of 
both Cloisite 93A and Cloisite 30B particles is as follows: 10% less than 2 mm; 50% less than 6 
mm and 90% less than 13 mm.  Cloisite 93A has a basal d001 of 23.6 Ȧ, while the d001 for 
Cloisite 30B particles was 18.5 Ȧ, per the manufacturer. 
 
 
Figure 1.  Chemical structure of the organic modifiers used in Cloisite 30B (A) and 
Cloisite 93A (B), methyl tallow bis-2-hydroxyethyl quaternary ammonium and methyl 
dehydrogenated tallow ammonium, respectively 
Two different polymers were used as the matrix component of the nanocomposite.  Both 
polymers were based on pure poly-D-lactide (PDLA, SurModics Biomaterials, Birmingham, AL) 
and had inherent viscosities in the range of 0.60 – 0.80 dL/g.  Terminal group chemistries 
differed between polymers, as one polymer was terminated by an ester group (PDLA-E) and the 
other by a carboxylic acid (PDLA-A).  All polymers were stored in air-tight containers until 
processing at a temperature of -20
o
C.   
Nanocomposite Synthesis 
A. B. 
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 To create PDLA-nanoclay composites, polymers were ground to an average particle size 
of 100-300 m.  Cloisite 30B or Cloisite 93A were mechanically mixed at ambient conditions 
with either PDLA-E or PDLA-A at 2.5 wt%.  This concentration has been previously shown to 
result in a significant increase in compressive mechanical properties for scCO2-processed 
nanocomposites composed of ester terminated PDLA and Cloisite 93A.  After mechanical 
mixing, the polymer-nanoclay mixtures were placed in a steel mold within a pressure vessel.  
The vessel was filled with CO2 until an internal pressure of 2000 psi was obtained, while 
maintaining the temperature of the vessel at 90
o
C.  The vessel was maintained at this pressure 
and temperature for 60 minutes.  After 60 minutes, the system was rapidly depressurized at a rate 
of 2-4 bar/s.  Following processing, the nanocomposites were stored at -20
o
C for 30 minutes 
before removal from the molds.   
Small Angle X-ray Diffraction 
The intergallery spacing of nanoclay within the resorbable polymer matrices was 
assessed by small angle X-ray diffraction (SAXD).  Supercritcial CO2-processed nanocomposites 
were sectioned into small fragments using a scalpel and palced in a custom zero-background 
quartz sample holder.  Using a RigakuSmartLab Diffractometer with a Cu-Kα X-ray source (λ = 
1.54 Å) and an accelerating voltage of 40 kV at a current of 40 mA, scans were collected from 
0.1 to 10
o
 2 at a rate of 3.0 deg/min with a step size of 0.30 degrees. Several scans were 
obtained from different locations in the particulate sample and verified to be reproducible by 
superimposing diffraction patterns. The 2θ angle corresponding to the [001] peak was 
determined by analyzing the diffraction spectra with software onboard the diffractometer.  
Bragg’s Law of diffraction was then used to calculated the intergallery spacing of the nanoclyas 
within the polymeric matrix, subtracting 1.0 nm to account for clay platelet thickness.  SAXD 
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scans of pure Cloisite 30B and Cloisite 93A were also obtained in the same manner to verify the 
supplier-provided d001 spacing of the nanoclays. 
 
Rheology 
To determine the impact of polymer end functionality and the method of nanoclay 
organic modification on dynamic mechanical properties, melt-rheological measurements were 
performed. Supercritical CO2-processed nanocomposites were heat pressed into rectangular 
molds between Teflon-coated stainless steel platens at a temperature of 80
o
C.  Samples were 
than annealed in a vacuum oven at 80
o
C to remove residual CO2, which could negatively impact 
rheology measurements.  Following adequate removal of residual CO2, melt rheological 
measurements were performed under oscillatory shear using a Rheometric Scientific RSA II 
rheometer.  Rectangular specimens (15.98 mm x 12.7 mm x 0.55 mm) were loaded on the 
machine in a shear sandwich geometry and allowed to equilibrate for one hour.  Rheological 
measurements were performed at 80ºC and 120ºC for all samples, and time-temperature 
superposed to create master curves with a reference temperature of 80
o
C.  A frequency range of 
0.01-100 rad/s was employed.  Storage (G’) and loss (G’’) moduli were plotted against frequency 
on the master curves.  Melt rheological measurements of nanocomposites were compared to 
those obtained for pure polymers. 
 
Results 
 As-received Cloisite 30B and Cloisite 93A exhibited a d001-spacing of 1.98 nm and 2.62 
nm, respectively, which corresponds to an intergallery spacing of 0.98 nm and 1.62 nm, 
respectively.  scCO2-processing of polymer-clay nanocomposites resulted in a shift in the 2 
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peak position, as shown in Figure 2, which corresponded to an increase in intergallery spacing 
for all polymer-clay combinations, as shown in Table 1.   
 
Figure 2.  Small angle X-ray diffraction (SAXD) of Cloisite 93A, Cloisite 30B and 
nanocomposites of 100PDLA-ester or 100PDLA-acid with each of the nanoclays. 
  
Cloisite 30B displayed the largest increases in intergallery spacing from the as-received 
state with an increase of 2.15 nm with PDLA-Ester constructs and 2.55 nm with PDLA-Acid 
constructs.  Cloisite 93A also displayed significant increases in intergallery spacing with a 1.39 
nm dilation when processed with PDLA-Ester and 1.69 nm  when processed with PDLA-Acid.  
Acid-terminated polymers yielded the largest increases in clay intergallery spacing in both cases.   
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Table 1.  Peak positions and corresponding d001-spacing of as-received Cloisite 93A, Cloisite 
30B and scCO2-processed nanocomposites of PDLA and nanoclay. 
Clay Matrix Peak Position (2) d001-Spacing Increase in 
Intergallery 
Spacing 
Cloisite 93A None 3.36 2.62 nm -- 
Closite 30B None 4.46 1.98 nm -- 
Cloisite 93A PDLA-Ester 2.20 4.01 nm 1.39 nm 
Cloisite 93A PDLA-Acid 2.61 3.38 nm 1.69 nm 
Cloisite 30B PDLA-Ester 2.13 4.13 nm 2.15 nm 
Cloisite 30B PDLA-Acid 1.95 4.53 nm 2.55 nm 
 
 Dynamic oscillatory shear measurements demonstrate that acid-terminated PDLA 
nanocomposites have lower storage (G’) and loss (G’’) moduli compared to ester-terminated 
PDLA nanocomposites across a range of frequencies, as shown in Figure 3.  Improvements in 
both G’ and G’’ were seen for all nanocomposite constructs over pure polymers. 
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Figure 3.  Rheological measurements performed at 80
o
C and 120
o
C time-temperature 
superposed to create a master curve of G’ and G’’ at a reference temperature of 80oC. 
  
Both ester-terminated polymers exhibited a shift in the G’-G’’ cross-over frequency, as 
shown in Figure 4.  This effect was most pronounced for PDLA-Ester-93A nanocomposites and 
is indicative of a reduction in characteristic relaxation time of the polymer.  G’ and G’’ were 
slightly increased by combining ester-terminated PDLA with Cloisite 30B, but less noticeable 
after the addition of Cloisite 93A.  Almost no shift in the G’-G’’ cross-over frequency was 
observed for acid-terminated polymers was observed.  Similarly the magnitude of G’ and G’’ 
were unchanged with the addition of Cloisite 93A to acid-terminated PLDA.  In contrast, G’ and 
G’’ increased significantly when Cloisite 30B was added to the acid-terminated PDLA.   
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Figure 4.  G’ and G’’ plotted against frequency for pure polymers (Top Left), PDLA-93A 
nanocomposites (Top Right) and PDLA-30B nanocomposites (Bottom). 
 
  Tan (), which is the ratio of G’’ and G’, was similar between pure and 
nanocomposite constructs, as shown in Figure 5.  Acid-terminated polymers did show a slightly 
higher value of this ratio, which is an indicator of the elasticity of the polymer melt.  Ester-
terminated PDLA with Cloisite 93A and Cloisite 30B resulted in a reduction of Tan() indicating 
a loss of elasticity upon nanoclay addition. 
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Figure 5.  Tan () of pure and nanocomposite materials. 
Discussion 
 All nanocomposite constructs exhibited an increase in the intergallery spacing of 
nanoclay, regardless of end functionality and nanoclay modifier.  Acid-terminated PDLA 
resulted in greater increases in spacing, compared with the ester-terminated polymer.  Further, 
the greatest increase in intergallery spacing was seen with ester-terminated PDLA and Cloisite 
30B.  These results suggests that there is an effect of both polymer end functionality and 
nanoclay modifier on the scCO2-mediated dispersion of nanoclay in polymer matrices.  It has 
been previously demonstrated that modification of nanoclay particles to improve interaction with 
polymer chains leads to an improvement in dispersion.  Chen, et al. grafted epoxy groups onto 
nanoclay particulate and demonstrated significant improvements in dispersion in poly(L-lactide) 
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(PLLA) matrices (Chen et al., 2005).  Tsimpliarki, et al. also investigated the role of nanoclay 
surface chemistry on dispersion within a PLLA matrix (Tsimpliarki et al., 2011).  Both of these 
studies focused exclusively on the modification of nanoclay, independent of its organic 
modification, which increases basal plaetelet spacing.  To the authors’ knowledge this is the first 
study which examined the role of both polymer end functionality and chemistry of organic 
modifiers in as-received organically modified Montmorillonite clays on dispersion.       
 Improvements in rheological behavior of the polymers were seen when Cloisite 93A or 
Cloisite 30B were added.  The most significant improvement observed was a shift in the G’, G’’ 
cross-over frequency for PDLA-Ester-93A, which is indicative of a reduction in the 
characteristic relaxation time of polymer chains.  A reduction in this relaxation time suggests 
more solid-like behavior as a result of the restriction of polymer chain mobility by the dispersed 
nanoclay (Horsch et al., 2006; Manitiu et al., 2008; Pavlidou and Papaspyrides, 2008; Ray and 
Okamoto, 2002).  Noticeable improvements in G’, G’’ and Tan() were observed upon the 
addition of Cloisite 93A or Cloisite 30B to PDLA-Acid.  As measurements were not carried out 
at low frequency ranges, further characterization of rheological behavior of pure and 
nanocomposite materials was not possible.  However, the improvements seen at higher 
frequencies are indicative of nanoclay-dependent reinforcement of the polymer matrices.  The 
most significant improvements were seen for acid-terminated PDLA.  It is unclear if this effect is 
a function of differential interaction between the carboxylic acid end groups of the polymer and 
the two different nanoclay modifiers, or if this is simply a function of the difference in initial 
viscosities between PDLA-Ester and PDLA-Acid.   
To further elucidate the influence of polymer end functionality and nanoclay modifier, 
future rheological measurements should be performed at a lower frequency range (Maiti et al, 
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2002; Ray et al., 2002; Ray et al., 2002).  Considerable sample degradation was observed for 
frequency ranges below 0.001 rad/s for both pure and nanocomposite samples.  For lower 
frequency ranges, a lower temperature should be used to minimize sample degradation.  The 
principle of time-temperature superposition can then be applied so that data performed at higher 
frequencies (and higher temperatures) can still be analyzed simultaneously.  
Conclusions 
 Supercritical CO2-processed PDLA-clay nanocomposites show considerable dispersion 
during small angle X-ray diffraction measurements.  This dispersion seems to be dependent on 
both the polymer end functionality and the organic modifier of the clay.  Further, dynamic 
oscillatory shear measurements show improvements in rheological behavior of polymer-
nanoclay nanocomposites.  While it remains unclear if this improvement in construct rheology is 
a function of polymer end group – nanoclay modifier interaction, differential improvements were 
observed based on the different clays and polymers tested.  We have demonstrated a method of 
tailoring dispersion and dynamic mechanical properties through modification of polymer and 
nanoclay surface functionality. 
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CHAPTER 7:  IN VIVO INFLAMMATORY RESPONSE TO AND OSTEOINDUCTIVE 
CAPACITY OF PDLA-NANOCLAY COMPOSITES PROCESSED BY 
SUPERCRITICAL CARBON DIOXIDE 
Introduction  
 Owing to the disadvantages associated with autologous and allogenic bone grafts 
(autograft and allograft, respectively), there is significant interest in developing synthetic 
substitute materials to enhance in vivo bone growth in clinical applications, such as fracture 
healing, arthroplasty and spinal arthrodesis (Rezwan et al., 2006; Khan et al., 2008; Moroni et 
al., 2009).  Resorbable polymers, based on polymerized lactic- and glycolic acid are excellent 
candidate materials due to their nearly four-decade history of clinical use, predictable 
degradation kinetics and myriad options of processing (Rezwan et al., 2006; Khan et al., 2008).  
In order to support in vivo bone formation capable of withstanding biomechanical loading, these 
polymers must possess a three dimensional porous morphology.  Average pore diameters in the 
range of 100-300 m are necessary to support cellular infiltration and neovascularization, which 
are both integral components to osteogenesis (Khan et al., 2008).   
 Methods such as thermal- or pressure-induced phase separation, particulate leaching and 
three dimensional printing have been used to create porous constructs from resorbable polymers 
().  While these methods are effective in terms of induction of an appropriate porous morphology 
for bone tissue engineering, the poor static mechanical properties of the constructs preclude their 
use in load bearing applications.  To enhance the mechanical performance of these constructs, 
researchers have attempted to reinforce the polymeric matrices with a variety of micro- and 
nano-structured filler materials, including hydroxyapatite, phosphate glass and carbon nanotubes 
(Rezwan et al., 2006; Khan et al., 2008; Georgiou et al., 2007; Mathieu et al. 2005).  Modest 
gains in compressive mechanical properties have been observed to date, which is often attributed 
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to poor dispersion of the filler in the matrix, as well as poor interaction between the filler and 
matrix (Georgiou et al., 2007).  Supercritical carbon dioxide (scCO2) processing of organo-
modified nanoclays with poly-D-lactide (PDLA) polymers has shown promise in the rapid 
production of porous resorbable nanocomposites for structural bone graft substitute applications 
(Baker et al., 2011).  With as little as 2.5 wt% of nanoclay, the compressive mechanical 
properties of the nanocomposite are nearly twice that of pure polymer scaffolds processed by 
scCO2.  The static compressive mechanical properties of scCO2-processed resorbable polymer 
nanocomposites also compare favorably to native cortico-cancellous bone.  Likewise, the porous 
structure of the nanocomposite constructs mimics the dense shell-porous core morphology of 
clinically-used autologous and allogenic bone graft materials, such as those harvested from the 
antero-superior region of the iliac crest (Baker et al., 2009; Baker et al., 2011; Chau and Mobbs, 
2009; Moroni et al., 2009). 
 The use of filler materials with micron and sub-micron dimensions raises a concern 
regarding the potential immune and inflammatory response to the particulate debris as scaffolds 
degrade in vivo.  Materials used in total joint arthroplasty and spine surgery, such as cross-linked 
polyethylene, poly methyl methacrylate, titanium alloy and CoCrMo alloys have been shown to 
induce a potent inflammatory response when the material is reduced to a particulate state during 
in vivo mechanical wear (Hallab et al., 2003; Jacobs et al., 2006).  This multifactorial response 
begins with engulfment of particulate debris by local macrophages (Ingham and Fisher, 2005; 
Purdue et al., 2007; Holt et al., 2007).  Responding macrophages express pro-inflammatory 
cytokines, including tumor necrosis factor-alpha (TNF-), interleukin-1beta (IL-1), interleukin-
6 (IL-6), interferon-gamma (IFN-) and granulocyte/macrophage-colony stimulating factor (GM-
CSF) (Ingham and Fisher 2005; Purdue et al., 2007; Smith et al., 2010; Smith et al., 2010).  The 
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expression of these cytokines is dependent on particle characteristics, such as size, concentration, 
composition and surface area (Wooley et al., 2002; Jacobs et al., 2006; Yang et al., 2002).  These 
cytokines are chemotactic for a number of immune cells, including monocytes.  Monocytes 
recruited to the site by the inflammatory cytokines differentiate into osteoclasts with active bone 
resorptive capacity (Holt et al., 2007; Purdue et al., 2007).  Activated osteoclasts begin to resorb 
local bone, while the anabolic potential of osteoblasts and osteocytes are suppressed by cytokines 
in both an autocrine and paracrine fashion (Vermes et al., 2001; Kanaji et al., 2009; Fuji et al., 
2011).  The net result, if particle concentration is sufficiently high, or increasing is the creation 
of cavitary defects in bone, which can compromise the stability of implants or lead to fracture 
(Hallab et al., 2003; Jacobs et al., 2006).  A revision procedure is often necessity following 
particle-induced osteolysis in orthopaedic patients.  
Particle-induced osteolysis may be an important factor to consider for resorbable polymer 
nanocomposites, such as scCO2-processed PDLA-nanoclay constructs.  As the nanocomposites 
are comprised primarily of a polymer that will undergo hydrolytic degradation in vivo, the final 
disposition of the nanoclay particles is of interest.  It is not currently known if the 
nanocomposites will degrade to a final state of bare nanoclay, or if a particulate form of the 
nanocomposite will arise as a function of both hydrolysis and cyclic mechanical loading.  If the 
nanoclay persists in “bare” form (not coated with polymer) a  significant body of work suggests 
that silicate-based materials possess a surface functionality conducive to mineralization.  
Ishikawa, et al. profiled the morphology, alkaline phosphatase activity and markers of 
mineralization in murine osteoblasts on aluminosilicate nanotubes (Ishikawa et al., 2010).  The 
group found an enhancement of osteoblastic differentiation, proliferation and active 
mineralization (Ishikawa et al., 2010).    If the particulate remains in composite form (i.e. 
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nanoclay agglomerates coated with PDLA) until complete polymeric degradation, a local 
inflammatory response may develop in an effort to sequester the particles.  The same theory of 
particle-induced osteolysis holds for several other resorbable polymer nanocomposite systems.  
Hydroxyapatite is a common filler in synthetic bone graft substitutes, due to the 
osteoconductivity of bulk hydroxyapatite.  However, in vitro studies have illustrated the 
inflammatory and osteolytic potential of calcium phosphate particulate (Bloebaum et al., 1998; 
Sbokbar et al., 2001; Kalmodia et al., 2011). 
In an effort to determine the immune and inflammatory response to resorbable polymer 
nanocomposite constructs, a study has been performed to characterize the osteolytic potential of 
bare particulate (filler only) and nanocomposite particulate (small particles of filler with 
polymer).  Hydroxyapatite has been used as a positive control, as it is a material used frequently 
in bone graft substitute  materials in both a clinical and pre-clinical setting.  Exposure to bare 
particulate is meant to represent the worst case scenario, with a completely resorbed polymer 
matrix exposing the filler material to the biologic environment.  A more likely scenario is 
represented by the nanocomposite particulate.  Under cyclic loading, resorbable polymer 
nanocomposites are hypothesized to reduce to small particles composed of both polymer and 
clay.  Additionally, an ectopic osteogenesis assay was performed to determine if bone formation 
is influenced by the incorporation of organically-modified Montmorillonite clay in a PDLA 
matrix.    
Materials and Methods  
In Vivo Inflammation Study 
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The murine air pouch model, established by Wooley, et al. is a well-defined system for 
assaying the inflammatory and osteolytic potential of the particulate form of materials used in 
orthopaedic surgery (Wooley et al., 2002; Yang et al., 2002; Yang et al., 2002; Ren et al., 2006; 
Ren et al., 2006).  In accordance with an IACUC-approved protocol, 20 female Balb/C mice 
underwent serial injections of air (1 c.c. each)on the dorsum to create a highly biologically 
active, fluid-filled pouch.  Air injections were performed every other day for a period of 5 days.  
On day five, after confirming the integrity of the air pouch, the mice were injected with 
bareparticulate (no polymer) according toTable 1.   
Table 1.  Treatment groups for bare particulate inflammation study. 
Filler Polymer Sample Size Concentration 
(mg/mL) 
None (PBS 
control) 
None (PBS 
control) 
5 N/A 
Hydroxyapatite None 5 100 
Cloisite 93A None 5 100 
Cloisite 30B None 5 100 
 
A separate phase of the study was conducted to examine the inflammatory response to 
nanocomposite particulate, as described in Table 2.  Particulate in this format is thought to be a 
more accurate representation of debris that would be generated in vivo during construct 
degradation.  In accordance with the same IACUC-approved protocol, 25 female Balb/C mice 
underwent serial injections of air (1 c.c. each) on the dorsum for a period of 14 days.  Air 
injections were performed every other day for the first 7 days until the pouch remained stable 
and inflated.  Injections were performed every two days after that.  On day 14, after confirming 
the integrity of the air pouch, the mice were anesthetized with 1-2% inhaled isoflurane and the 
air pouches were incised.  A 1.0 cm incision provided adequate access to the pouch.  Following 
the incision, 100 mg of particles were implanted into the pouch.  The incision was closed with 5-
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0 Prolene suture and wound adhesive (NexaBand) was applied to create a water tight closure.  
After closure, the dorsum pouches were injected with 0.5 cc of saline. 
 
Table 2.Treatment groups for polymer and nanocomposite particulate inflammation study. 
Filler Polymer Sample Size Mass of Particles 
None (PBS control) None 5 N/A 
None (polymer only) 100 PDLA 5 100 mg 
Hydroxyapatite 100PDLA 5 100 mg 
Cloisite 93A 100PDLA 5 100 mg 
Cloisite 30B 100 PDLA 5 100 mg 
 
Mice were allowed ad libitum activity and free access to food and drink following the 
particulate injection.  48 hours after exposure, the animals were euthanized by asphyxiation in a 
CO2 chamber and subsequently underwent cervical dislocation as a means of assurance of death.  
Dorsal pouch tissue was aseptically harvested with care to ensure that membranous tissue 
remained intact and sectioned into two equal volume specimens.  Half of the tissue was 
immersed in zinc-buffered formalin, while the remainder was snap frozen in liquid nitrogen and 
subsequently stored at -80
o
C until analysis. 
Preparation of Polymer and Nanocomposite Particles for Inflammation Study 
For animals receiving an injection of bare particulate (no polymer), ultrasonication in 
70% ethanol was used to remove bound endotoxin from the particles.  Following 10 minutes of 
sonication in 70% ethanol, the particles were transferred to 95% ethanol and left to dry in a 
sterile laminar flow culture hood overnight.  Particulate was then rinsed three times with sterile 
PBS andresuspended in sterile PBS at a concentration of 100 mg/mL immediately prior to 
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injection.  Each volume was vortexed prior to injection to ensure an equal distribution of 
particulate. 
Polymer-coated particulate was utilized to simulate debris generated in vivo during the 
hydrolytic breakdown of PDLA.  Freeze fracturing and subsequent grinding of scCO2-processed 
polymers and nanocomposites failed to produce a particle size conducive to implantation.  As 
such, a solvent casting method was used in the production of polymer and nanocomposite 
particulate.  The solvent casting method consisted of dissolving 2.0 g of 100PDLA in 50mL of 
chloroform under constant agitation.  Following adequate dissolution, particulate 
(hydroxyapatite, Cloisite 93A or Cloisite 30B) was stirred in until a homogenous mixture was 
obtained.  Hydroxyapatite was loaded into the polymer at 45wt%, while Cloisite 93A and 
Cloisite 30B were loaded at 2.5wt%.  The disparity in the amount of filler is reflective of the 
high hydroxyapatite content used by other researchers to achieve adequate increases in 
mechanical properties (Rezwan et al., 2006; Khan et al., 2008).   
The mixtures were then cast in sterile Pyrex petri dishes.  Mixtures were allowed to air 
dry for 24 hours in a sterile laminar flow hood.  Following air dyring, the mixtures were 
lyophilized at a pressure of 0.045mBar for 48 hours.  Particulate of a size conducive to injection 
was generated from the dried mixtures by a combination of chopping with a razor and grinding 
with mortar and pestle under liquid nitrogen.  Particulate was suspended in 70% ethanol and 
ultrasonicated for 10 minutes to remove any bound endotoxin and subsequently transferred to 
absolute ethanol to drive off extra water.  The particulate was again lyophilized at a pressure of 
0.045 mBar for 96 hours in RN-ase and DNA-se free cryotubes in premeasured 100 mg doses.  
Approximately 200 mg of each particulate mixture was kept for imaging by scanning electron 
microscopy. 
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Histology and Cytokine Analysis 
Half of the harvested pouch tissue was dehydrated and embedded in paraffin.  5.0m 
sections were created using a microtome and subsequently stained with hematoxylin and eosin 
(H&E).  Five H&E slides per pouch were cut for analysis.  The H&E-stained sections were 
analyzed under a light microscope to qualitatively assess the infiltration of the pouch tissue by 
inflammatory and immune cells.  Additionally, measurements of membrane thickness were made 
using digital image analysis software (Scion Image, Scion Corp.).  An average of eight 
measurements per slide were made.   
The remainder of the pouch tissue was homogenized in a buffer solution containing a 
protease inhibitor cocktail and TritonX100.  The concentration of five pro-inflammatory 
cytokines including interleukin-1beta (IL-1), interleukin-6 (IL-6), granulocyte/macrophage-
colony stimulating factor (GM-CSF), macrophage inflammatory protein-2 (MIP-2) and 
interferon-gamma (IFN-), was quantified using a bead-based multiplex ELISA (Human Pro-
inflammatory Cytokine Panel A, R&D Systems Inc., Minneapolis, MN).  Cytokine expression 
was normalized to the total protein content in each sample, as determined by a total protein 
assay.   
Preparation of Polymer and Nanocomposite Implants for Osteoinductivity Study 
Ectopic osteogenesis assays are commonly used tools to study the ability of a scaffold to 
induce or support bone formation (Ishaug-Riley et al., 1997; Jeon et al., 2007; Ji et al., 2010; 
Barbieri et al., 2010).  For the ectopic osteogenesis phase of the experiment, porous constructs 
were synthesized using scCO2 processing, as previously described (Baker et al., 2009; Baker et 
al., 2011).  Pure PDLA (no clay) constructs were processed at a temperature of 35
o
C and a 
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pressure of 2000 psi.  After 60 minutes of exposure to scCO2, the reactor vessel was rapidly 
depressurized to produce a porous construct.  Nanocomposite constructs, comprised of PDLA 
and 2.5wt% Cloisite 93A, were also synthesized with scCO2 processing.  A processing 
temperature of 90
o
C and a pressure of 2000psi was used to generate constructs with a pore size 
similar to the pure PDLA constructs.  Following scCO2 processing, all materials were handled 
aseptically and stored in sterile locations. 
A biopsy punch was used to take porous cores from the constructs with a diameter of 6.0 
mm.  The cores were then sectioned into discs with a thickness of 1.0 mm.  While the specimens 
were handled aseptically, discs were nonethelessultrasonicated in 95% ethanol for 15 minutes to 
remove any bound endotoxin.  Following drying, discs were stored in a sterile laminar flow hood 
until use. 
Half of the pure polymer discs and half of the nanocomposite discs were selected at 
random for growth factor loading.  Discs were immersed in 100 L of a solution of E. Coli-
expressed recombinant human bone morphogenetic protein-2 (rhBMP-2, R&D Systems Inc., 
Minneapolis, MN).  The solutions were comprised of rhBMP-2 reconstituted with 4.0 mMHCl at 
a protein concentration of 100 g/mL (potential for 20 g of rhBMP-2 per disc) per 
manufacturer’s instructions.  After 10 minutes of immersion, which is consistent with current 
clinical use of rhBMP-2, the discs were removed from the solutions and air dried.   
In Vivo Osteoinductivity Assay 
In accordance with an IACUC-approved protocol, 36 female Balb/C mice were 
anesthetized and dorsum shaved.  After preparing the surgical site in a sterile fashion, an incision 
was made on the dorsum of the mice over the hind limb.  The gluteus muscle was identified and 
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an intramuscular pouch was created using blunt dissection.  Upon preparation of the gluteal 
pouch, polymer or nanocomposite discs, according to Table 3, were inserted.  The limb was 
ranged to ensure a low likelihood of extrusion of the disc during normal gait.  Wounds were 
closed with suture and wound adhesive and the animals were allowed ad libitum activity upon 
recovery from the anesthetic.   
Table 3.  Treatment groups for the in vivo osteoinductivity assay. 
Group Description n Time Points 
1 100PDLA 9 2, 4 and 6 weeks 
2 100PDLA + 20 g of rhBMP-2 9 2, 4 and 6 weeks 
3 100PDLA-2.5wt% 93A 9 2, 4 and 6 weeks 
4 100PDLA-2.5wt% 93A + 20 g of rhBMP-2 9 2, 4 and 6 weeks 
 
Histology and -Computed Tomography Analysis 
Mice were sacrificed at two, four and six post-operative weeks by CO2 asphyxiation and 
subsequent cervical dislocation.  Euthanized mice underwent CT analysis of ectopic bone 
formation.  A scan power of 80 kVp and a voxel size of 50 m2 was used for all animals.  
Reconstructed DICOM images were analyzed by ImageJ software (National Institutes of Health, 
Bethesda, MD). 
Following CT imaging, the gluteal pouch and contents were aseptically harvested and 
immersed in zinc-buffered formalin.    Specimens were dehydrated and embedded in paraffin.  
5.0m sections were taken from the specimens and stained with H&E.  Approximately five H&E 
slides per animal were cut and analyzed by light microscopy. 
Results  
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Inflammatory Response to Bare Particulate 
 All animals tolerated both the air injections, as well as the particle injections.  Multiplex 
ELISA analysis of pro-inflammatory cytokine expression within the pouch tissue showed a 
substantial increase in IL-1, IL-6 and MIP-2 for mice receiving injections of Cloisite 30B and 
Cloisite 93A, compared to PBS control and hydroxyapatite particles, as shown in Figure 
2.Cloisite 93A particles elicited the highest level of IL-1b (93.8 +/- 44.8 pg/mL), which was 
significantly higher than both PBS controls (p = 0.009, 14.4 +/- 2.6 pg/mL) and hydroxyapatite 
(p = 0.014, 18.6 +/- 7.4 pg/mL), but not significantly higher than Cloisite 30B (p=0.67, 58.9 +/- 
47.4 pg/mL).  Cloisite 93A particles also induced the highest expression of IL-6 (545.6 +/- 272.2 
pg/mL), which was again significantly higher than PBS control (p<0.001, 12.1 +/- 3.6 pg/mL) 
and hydroxyapatite particles (p=0.001, 11.3 +/- 4.1 pg/mL), but not significantly different than 
Cloisite 30B (p=0.590, 362.4 +/- 132.6 pg/mL).  GM-CSF was highest in the Cloisite 93A group 
(20.7 +/- 14.7 pg/mL), followed by Cloisite 30B (17.8 +/- 14.5 pg/mL), PBS controls (0.4 +/- 0.5 
pg/mL) and hydroxyapatite (0.4 +/0 0/4 pg/mL).  No significant difference was found between 
the groups in terms of GM-CSF expression, which may have been due to a Type II statistical 
error.  MIP-2 expression was again highest for the Cloisite 93A group (312.9 +/- 0.00), which 
was significantly higher than all other groups (p<0.001).  In contrast, IFN-g expression was 
highest for PBS controls (25.8 +/- 3.2 pg/mL), which was significantly higher than Cloisite 93A 
(p=0.017, 12.1 +/- 6.1 pg/mL), but not significantly different from the hydroxyapatite group 
(p=1.00, 24.7 +/- 7.9 pg/mL) or the Cloisite 30B group (p=0.236, 17.2 +/- 6.4 pg/mL). 
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Figure 1.  Multiplex ELISA characterization of pro-inflammatory cytokine expression in air 
pouch tissue injected with PBS (control), hydroxyapatite particles, Cloisite 30B or Cloisite 93A. 
  
Analysis of histolgic sections of the mouse pouch tissue revealed a thick membranous 
tissue structure within the core of specimens, as shown in Figure 2.  This was likely the reactive 
membrane formed both by serial injections of air, as well as injections of particulate.  
Inflammatory infiltrate was observed to be more intense in animals receiving injections of 
Cloisite 93A and Cloisite 30B.  Cellular contents of the infiltrate tissue was predominantly 
histiocytes, which is indicative of an early phase of inflammatory response.  Foreign body giant 
cells were identified in the tissue samples from mice receiving Cloisite 30B particulate.  
Inflammatory infiltrate in tissues from mice receiving hydroxyapatite particles was minimal.  
Cell contents of these tissue sections were predominantly fibroblastic, similar to the control 
tissues. 
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Figure 2.  Histologic sections of mouse air pouches that received saline injection (top left), 100 
mg/mL of hydroxyapatite particulate (top right), Cloisite 93A (bottom left) and Cloisite 30B 
(bottom right) particulate. 
Histologic evaluation of pouch tissues harvested after 48 hours of exposure to Cloisite 
93A, Cloisite 30B, hydroxyapatite or PBS revealed significant differences in membrane 
thickness, as shown in Figure 3.  Tissues exposed to Cloisite 30B had the thickest membranes 
(598.31 +/- 137.22 m), which was not significantly different from those exposed to 
hydroxyapatite (p=1.00, 572.39 +/- 90.60 m), but was significantly higher than tissues from 
PBS controls (p=0.004, 507.61 +/- 114.00 m) and Cloisite 93A (p<0.001, 470.77 +/- 115.95 
m).  Membrane thickness in tissues exposed to Cloisite 93A particles was significantly lower 
than tissues exposed to hydroxyapatite (p<0.001), but not significantly lower than tissues 
exposed to PBS (p=0.937). 
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Figure 3.  Histological measurements of air pouch membrane thickness from mice receiving an 
injection of PBS, hydroxyapatite (calcium phosphate), Cloisite 30B and Cloisite 93A.   
 
Inflammatory Response to Nanocomposite Particulate 
 Nanocomposite particulate produced by solvent casting and subsequent grinding under 
liquid nitrogen results in similar sizes and morphologies between the treatment groups.  All 
particles possessed a prismatic morphology and apparent aspect ratio of 2:1, with a minor axis of 
approximately 250 m.  PDLA-HA particulate tended to have a greater degree of nanotexture, 
which may be the result of the relatively high filler content.  PDLA-93A and PDLA-30B 
particulate, though prismatic in nature, displayed fibrillar protrusions from the main body of the 
particles, as shown in Figure 4.  
 126 
 
 
 
Figure 4.  Scanning electron micrographs of polymer and nanocomposite particulate debris.  
100PDLA (top left), 100PDLA-45wt% HA, (top right), 100PDLA-2.5wt%93A (bottom left) and 
100PDLA-2.5wt%30B (bottom right).   
 One mouse was lost due to a pulmonary embolism immediately following one of the air 
pouch injections.  All other animals tolerated both the air injections and particle implantions 
well, without incident.  All mice that underwent an open procedure to facilitate implantation of 
particulate showed measurable amounts of pro-inflammatory cytokines upon multiplex ELISA, 
as shown in Figure 5.  IL-6 was outside of the range of the standard curve for all tissue samples 
and is not reported.  MIP-2 expression was largest for PDLA-30B nanocomposite samples 
(2770.0 pg/mL +/- 1304.3 pg/mL).  This value was not statistically significant when compared to 
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PDLA-93A (p=1.00; 2312.4 +/- 697.0 pg/mL), or PDLA-HA particulate (p=1.00; 2119.1 +/- 
542.8 pg/mL).  PDLA (no filler) particulate induced the highest expression of IFN-g (175.9 +/- 
15.9 pg/mL).  No statistically significant differences were found with respect to IFN-g 
expression between treatment groups and controls.  PDLA-HA particulate yielded the greatest 
expression of IL-1b (250.4 +/- 111.3 pg/mL), though there was no significant difference when 
compared to PDLA (p=0.139; 111.5 +/- 76.1 pg/mL), PDLA-93A (p=1.00; 195.3 +/- 79.0 
pg/mL), or PDLA-30B(p=1.00; 184.8 +/- 61.6 pg/mL).  With regards to GM-CSF expression, 
PDLA-HA particulate again yielded the highest expression (20.0 +/- 9.8 pg/mL) without a 
significant difference found between any treatment group, or with controls.   
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Figure 5.  Multiplex ELISA characterization of pro-inflammatory cytokine expression in air 
pouch tissue with implanted PDLA particles, PDLA-45wt% hydroxyapatite nanocomposite 
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particles, PDLA-2.5wt%93A nanocomposite particles, PDLA-2.5wt% 30B nanocomposite 
particles and PBS (control). 
 
Osteoinductivity of rhBMP-2-Loaded Nanocomposites 
 All mice undergoing open implantation of pure PDLA and PDLA-93A discs tolerated the 
procedure well and none were lost to complications.  No animals exhibited constitutional 
symptoms or physical signs of infection.  Upon gross observation of tissues during harvest, no 
outwardly observable signs of deep infection or foreign body response were noted.  Micro-CT of 
the mice showed some reactive bone formation at the two week and four week time point in all 
mice receiving PDLA and PDLA-93A constructs without rhBMP-2, as shown in Figure 6.  This 
bone formation was slightly more pronounced in the mice receiving PDLA-93A nanocomposites.   
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Figure 6. Axial micro-CT images of in vivo bone growth after two weeks in mice receiving pure 
PDLA constructs (Top Left) and PDLA constructs with E. Coli-expressed rhBMP-2 (Bottom 
Left), compared to mice receiving PDLA-93A constructs (Top Right) and PDLA-93A constructs 
with E. Coli-expressed rhBMP-2 (Bottom Right). The red ring represents the area of construct 
implantation. 
By six weeks, the reactive bone formation had disappeared in constructs without rhBMP-
2, as shown in Figure 7.  Both construct types with adsorbed rhBMP-2 displayed a significant 
amount of bone formation at each of the three time points.  Simultaneous orthogonal projections 
(combined views of axial, sagittal and coronal sections) displayed evidence of appositional, as 
well as three dimensional bone growth.  No differences were observed between animals which 
received PDLA or PDLA-93A constructs, in terms of CT evidence of bone formation.  All 
animals receiving constructs with rhBMP-2 adsorbed did show more fluid accumulation in the 
gluteal pouch, which is consistent with growth factor-induced bone formation. 
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Figure 7.  Axial micro-CT images of in vivo bone growth in PDLA-93A nanocomposites with E. 
Coli-expressed rhBMP-2 (top right, bottom right) and without rhBMP-2 (top left, bottom left) at 
two weeks (top row), four weeks (middle row) and six weeks post-op. 
Discussion  
 In the simulated worst case scenario consisting of the exposure of filler materials directly 
to the biologic environment, without intervening polymer chains, both Cloisite 93A and Cloisite 
2 Weeks 
4 Weeks 
6 Weeks 
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30B particulate induced a significantly higher inflammatory response, compared to 
hydroxyapatite and saline controls.  In particular the cytokines IL-1, IL-6 and MIP-2 were 
significantly elevated in the clay-treated tissues.  While cytokine expression was significantly 
different, no similar trends were found in measurements of membrane thickness in the pouch 
tissues.  This could be due to the relatively short exposure of the pouch tissue to the particulate.  
Montmorillonite clay-induced inflammation is not well-described in the musculoskeletal setting.  
There is a paucity of data in general regarding the immune and inflammatory response to layered 
silicate structures in vivo and in vitro.  Styan et al., examined the in vitro response of fibroblasts 
to nanocomposites composed of polyurethane reinforced with nanoclays modified with 
quaternary ammonium compounds (QAC) similar in structure to Cloisite 30B (Styan et al., 
2008).  This group found a negative effect on fibroblast proliferation and viability and referred to 
this effect as cytotoxicity, though no studies were performed to confirm cytotoxicity, or rule out 
apoptosis and necrosis.  Liquid chromatography mass spectroscopy demonstrated leeching of 
QAC from the nanocomposites while in culture, which the authors posited led to the cytotoxicity 
(Styan et al., 2008).   Rueda, et al., also examining polyurethane polymers reinforced with 
Cloisite 30B, found a similar effect on fibroblast proliferation (Rueda et al., 2011).In contrast, 
Katti, et al. found that blends of chitosan-Montrmorillonite and hydroxyapatite supported 
osteoblast function with no observable reduction in viability (Katti et al., 2008).  
Montmorillonite was observed to act synergistically with hydroxyapatite in supporting cell 
function by the osteoblasts (Katti et al., 2008).  Zhuang, et al. also did not observe a negative 
effect of Montmorillonite clay in blends of gelatin and chitosan during in vitro analyses (Zhuang 
et al., 2007).  It should be noted that neither Katti, nor Zhuang utilized organically-modified 
Montmorillonite.  While Cloisite 93A is modified with a QAC, no in vitro or in vivo studies have 
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been performed to date to directly assess the effect of this specific QAC on cell viability or 
inflammatory response.   
 When the murine air pouches were challenged with nanocomposite particulate, the 
differences between nanoclay-loaded and hydroxyapatite-loaded constructs were not as 
substantial.  MIP-2 showed the greatest difference between PDLA-HA, PDLA-93A and PDLA-
30B with nanoclay-loaded particulate expressing greater concentrations of the cytokine, but this 
difference failed to reach statistical significance.  PDLA-HA particulate actually induced a 
higher expression of both IL-1 and GM-CSF, compared to PDLA-93A and PDLA-30B.  IL-6 
was not reported for the nanocomposites particulate challenge, as technical difficulties with this 
assay were noted.  Future work will include this analyte, as it has been shown to play an 
important role in inflammatory response and osteoclastogenesis.  These results may be attributed 
both to the reduction of direct contact between nanoclay particulate and the biological 
environment, as well as the difference in filler content between hydroxyapatite-loaded and 
nanoclay-loaded particulate.  Clinically-used products and pre-clinical tissue engineering 
constructs tend to use high concentrations of hydroxyapatite, both to enhance mechanical 
properties and to potentially facilitate osteoconduction.  Peng, et al. used 20 wt% hydroxyapatite 
in a nanospun PLLA nanocomposite scaffold, while Guan, et al. used up to 75 wt% of 
hydroxyapatite in a PLGAmatrix (Peng et al., 2011; Guan et al., 2004).  For the present study, 
nanocomposite particulate was loaded with 45 wt% hydroxyapatite, as this represented the 
median concentration of hydroxyapatite used in recent studies.  Nanoclay-PDLA particulate was 
loaded with 2.5wt% Cloisite 93A or Cloisite 30B, as this was the concentration previously 
shown to result in the greatest gains in compressive strength and modulus (Baker et al., 2011).  
Though not a focus of this study, scCO2-processed PDLA-93A constructs exhibit compressive 
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mechanical properties exceeding that of porous constructs with significantly higher 
concentrations of hydroxyapatite particulate. 
 Though the final disposition of nanoclay in PDLA nanocomposites remains as conjecture, 
a significant body of work exists detailing the mineralization of silicate structures.  It is likely 
that in the event of complete matrix degradation, nanoclay would be incorporated within the de 
novo bone.  Cunningham, et al. have demonstrated the incorporation of metallic debris within the 
developing posterolateral spine fusion mass in rabbits inoculated with titanium particulate 
(Cunningham et al., 2003).  Further, Cunningham and colleagues demonstrated no significant 
reduction in bone formation as a function of exposure to the particulate, despite significantly 
elevated pro-inflammatory cytokine production and osteoclast activity (Cunningham et al., 
2003).  Nanocomposites synthesized for this study are not intended to be used in bearing surface 
applications, such as total joint arthroplasty devices.  As such, the final size and morphology of 
particles will vary significantly with the particle sizes and morphologies used in in vitro and in 
vivo studies examining the osteolytic potential of mechanical wear debris.  No data currently 
exists, which has examined the physical characteristics of particulate shed from porous 
resorbable polymer nanocomposites as a function of cyclic loading in an aqueous media.  Future 
research will focus on creating nanocomposites particulate that more closely resembles the 
physical characteristics of debris found in vivo. 
 PDLA and PDLA-93A constructs synthesized by scCO2 processing showed the ability to 
support in vivo bone formation, when functionalized with E. Coli-expressed rhBMP-2.  Similar 
to other studies, the constructs displayed both appositional bone growth, as well as three 
dimensional infiltration of osteogenesis.  These results suggest that the interconnected, porous 
morphology of the constructs are sufficient for bone graft applications where three-dimensional 
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bone growth is desired and often achieved with the addition of exogenous growth factors.  No 
significant difference was noted between PDLA and PDLA-93A constructs in terms of bone 
growth at early time points.  This results suggests that, despite the increased inflammatory 
response to nanoclay when compared with hydroxyapatite at identical concentrations, bone 
growth remains unaffected.  Future studies will also seek to characterize neoangiogenesis 
associated with bone growth on the nanocomposites constructs.  Vessel formation is an important 
requirement for the growth of sustainable osseous tissue.  Results from the four week and six 
week timepoints, are encouraging, as bone resorption is a hallmark of non-viable and non-
nutrient supplied neo-osseous tissue. 
Conclusions  
 This is the first study to demonstrate the in vivo inflammatory response to Cloisite 30B, 
Cloisite 93A and nanocomposite particulate composed of these nanoclays dispersed in a PDLA 
matrix.  The inflammatory response to PDLA-93A and PDLA-30B nanocomposite particulate 
was substantially equivalent to the more traditional PDLA-HA compositions, suggesting 
appropriate biocompatibility.  Additionally, this study demonstrated the ability of supercritical 
carbon dioxide-processed PDLA-93A nanocomposites to support exogenous growth factor-
induced bone formation.  Supercritical CO2-processed resorbable polymer-clay nanocomposites 
may be suitable as bone graft substitute in load-bearing orthopaedic applications.  
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Numerous clinical situations necessitate the use of bone graft materials to enhance bone 
formation.  While autologous and allogenic materials are considered the gold standards in the 
setting of fracture healing and spine fusion, their disadvantages, which include donor site 
morbidity and finite supply have stimulated research and development of novel bone graft 
substitute materials.  Among the most promising candidate materials are resorbable polymers, 
composed of lactic and/or glycolic acid.  While the characteristics of these materials, such as 
predictable degradation kinetics and biocompatibility, make them an excellent choice for bone 
graft substitute applications, they lack mechanical strength when synthesized with the requisite 
porous morphology.  As such, porous resorbable polymers are often reinforced with filler 
materials.  In the presented work, we describe the use of supercritical carbon dioxide (scCO2) 
processing to create porous resorbable polymeric constructs reinforced by nanostructured, 
organically modified Montmorillonite clay (nanoclay).  scCO2 processing simultaneously 
disperses the nanoclay throughout the polymeric matrix, while imparting a porous morphology to 
the construct conducive to facilitating cellular infiltration and neoangiogenesis, which are 
necessary components of bone growth.  With the addition of as little as 2.5wt% of nanoclay, the 
compressive strength of the constructs nearly doubles putting them on par with human cortico-
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cancellous bone.  Rheological measurements indicate that the dominant mode of reinforcement 
of the nanocomposite constructs is the restriction of polymer chain mobility.  This restriction is a 
function of the positive interaction between polymer chains and the nanoclay.  In vivo 
inflammation studies indicate biocompatibility of the constructs.  Ectopic osteogenesis assays 
have determined that the scCO2-processed nanocomposites are capable of supporting growth-
factor induced bone formation.  scCO2-processed resorbable polymer nanocomposites composed 
of resorbable polymers and nanocaly exhibit physical, mechanical and biologic properties that 
make them excellent candidate materials for structural bone graft substitute applications.   
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